All articles tagged: Dermatology
HealthDay
20 November at 04.01 PM
Teledermoscopy Accurate for Detecting Skin CancersTeledermoscopy has high accuracy for detecting skin cancers, according to a research letter published online Nov. 9 in the Journal of the American Academy of Dermatology.Jenne P. Ingrassia, from New York Medical College in Valhalla, and colleagues conducted a prospective diagnostic accuracy study to compare the accuracy of telemedici |
MedScape
20 November at 12.59 PM
FDA Approves Bimekizumab for Hidradenitis SuppurativaThe development marks the fifth approved indication of the drug since October 2023. |
HealthDay
20 November at 11.06 AM
Four Million Americans Could Lose Health Coverage Once ACA Credits ExpireIf Congress lets health care tax credits established during the pandemic expire, 4 million Americans will become uninsured, a new analysis warns.The tax credits, which have significantly lowered out-of-pocket costs for millions of Americans, are set to expire at the end of 2025."Allowing these credits to expire will force families to c |
MedScape
20 November at 06.42 AM
Long-Term Risk for Some Skin Disorders Increased After COVIDA study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and autoinflammatory skin disorders, and vaccination may reduce these risks. |
MedScape
20 November at 06.23 AM
Study Compares Skin Toxicities of MEK Inhibitors in ChildrenDermatologic adverse events affected 97.8% of pediatric patients on MEK inhibitors, in a small retrospective single-center study. |
HealthDay
19 November at 11.50 PM
President-Elect Trump to Pick Mehmet Oz to Head CMSPresident-elect Donald Trump says he will nominate Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services.In a statement, Trump said that Oz will "work closely with Robert Kennedy Jr. to take on the illness industrial complex, and all the horrible chronic diseases left in its wake," The New York Times reported. Trump |
MedScape
19 November at 08.03 AM
Dupilumab Beneficial When Antihistamines Fall Short for CSUApproximately 30% of patients achieved complete remission after 24 weeks. |
MedScape
19 November at 05.30 AM
FDA Considers New Dupilumab Data for CSU IndicationAdditional phase 3 trial results confirmed improvement in hives and itching. |
MedScape
18 November at 02.47 PM
Topical Ivermectin Among Rx Options for Ocular RosaceaSymptoms of ocular rosacea may include only “a dry, gritty feel” to the eye and a red eyelid margin, according to dermatologist Julie Harper, MD. |
MedScape
18 November at 07.14 AM
Vulvar Dermatoses: Ob.Gyn Collaboration With Dermatologists“There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as they should, said Sarah Cigna, MD. |
MedScape
17 November at 11.51 AM
Expert-Backed Tips for Revitalizing Dystrophic NailsUrea nail preparations can be used to temporarily soften the nail. |
MedScape
16 November at 11.03 AM
How to Handle a Negative Patient ReviewBuilding emotional resilience can help mitigate emotional responses. |
HealthDay
15 November at 04.27 PM
Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and increasing, according to a study published online Oct. 30 in the Journal of the American Academy of Dermatology.Sarah L. Spaulding, from the Yale School of Medicine in New Haven, Connecticut, and colleagues characterize |
MedScape
15 November at 11.58 AM
Europe Rejects Cinainu (Alopecia) & Kizfizo (Neuroblastoma)The European Medicines Agency has refused marketing authorizations for an herbal medicine intended to treat alopecia areata and a hybrid drug for neuroblastoma in children. |
MedScape
15 November at 07.52 AM
Why Topical Retinoids Are Key to Every Acne RegimenThe drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent. |
HealthDay
14 November at 11.47 PM
President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHSPresident-elect Donald Trump has chosen Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services.The department encompasses numerous key agencies, including the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health, Medicaid, and Medicare.In a stat |
MedScape
14 November at 02.20 PM
SDPA Marks Its 30th Year of Supporting Physician AssociatesSDPA advocacy efforts include expansion of federal workers' comp policies to include coverage of care performed by PAs. |
HealthDay
13 November at 10.40 PM
Greater Fine Particulate Matter Linked to Increased Odds of EczemaThe odds of eczema are increased with greater exposure to fine particulate matter of diameter ≤2.5 μm (PM2.5), according to a study published online Nov. 13 in PLOS ONE.Gloria F. Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined the risk for eczema with PM2.5 exposure in a |
MedScape
13 November at 11.05 AM
Wounds in Fentanyl Users Exposed to Xylazine DescribedA case series characterized wounds associated with xylazine exposure, an increasingly common adulterant found in illicitly manufactured fentanyl in the United States. |
HealthDay
12 November at 09.32 PM
FDA Approves Emrosi for Rosacea in AdultsThe U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.The extended-release capsules (40 mg) will be available late in the first quarter or early in the second quarter of 2025.The approval was based on positive results from two 16-week phase 3 clinical tri |
HealthDay
12 November at 09.27 PM
Topical Human Platelet Extract Noninferior for Photoaging of HandsTopical human platelet extract (HPE) performs as well as topical vitamin C for skin rejuvenation of dorsal hands, according to a study published in the November issue of Plastic and Reconstructive Surgery.Saranya Wyles, M.D., Ph.D., from THE Mayo Clinic in Rochester, Minnesota, and colleagues conducted a prospective, longitudinal study |
MedScape
12 November at 03.04 AM
Low-Dose Oral Minoxidil Does Not Significantly Affect BPLow-dose oral minoxidil did not have a significant effect on blood pressure in patients being treated for alopecia, although it increased heart rate slightly, according to a systematic review and meta-analysis. |
MedScape
11 November at 06.03 AM
COVID-19 Linked to Increased Risk for Pemphigus, PemphigoidCOVID-19 infection increased the risk for autoimmune blistering diseases, but vaccination had protective effects, according to the results of a retrospective cohort study. |
HealthDay
08 November at 04.46 PM
COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory DiseaseCOVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.Yeon-Woo Heo, M.D., from the Yonsei University Wonju College of Medicine in South Korea, and colleagues conducted a retrospective cohort study to examine the long-ter |
MedScape
08 November at 11.19 AM
Ivermectin Found to Have Dual Effect in RosaceaIn addition to its effect on reducing Demodex in patients with rosacea, topical ivermectin may improve symptoms by changing the skin microbiome. |
MedScape
08 November at 04.09 AM
Hidradenitis Suppurativa Linked to Inflammatory Eye DiseaseAmong 355 patients with HS included in the systematic review, about 22% had inflammatory eye disease. |
HealthDay
07 November at 11.07 PM
Travel Time to Tanning Facilities Negatively Linked to Melanoma IncidenceThere is a negative association between travel time to tanning facilities and county-level melanoma incidence rates, according to a study published online Nov. 7 in the Journal of Investigative Dermatology.Guixing Wei, Ph.D., from Brown University in Providence, Rhode Island, and colleagues examined the association between melanoma inc |
HealthDay
07 November at 04.16 PM
Cutaneous Malignant Melanoma Incidence Increasing Among the ElderlyFrom 1987 to 2016, there was a considerable increase in the incidence of cutaneous malignant melanoma (CMM) among the elderly in the United States, according to a study published online Oct. 28 in Cancer Screening and Prevention.Ruofei Du, Ph.D., from Shaanxi University of Chinese Medicine in Xianyang, and colleagues examined CMM incid |
MedScape
07 November at 08.11 AM
Levonorgestrel IUDs Linked to Higher Skin Side EffectsLevonorgestrel IUDs were associated with increased risks for acne, alopecia, and hirsutism in a study of FDA adverse event reports. |
MedScape
06 November at 11.00 AM
ICIs Associated With Twofold Increased Psoriasis RiskPatients with cancer receiving immune checkpoint inhibitors had a twofold higher risk of developing psoriasis than those receiving chemotherapy or targeted therapy, according to the results of a cohort study. |
MedScape
05 November at 04.47 AM
Rising Trends in Skin Fungal Infections in the United StatesA 12-year study reported over 72 million patient visits for superficial cutaneous fungal infections in the United States. |
HealthDay
04 November at 11.44 PM
Policies About Late-Career Physicians Are Considered SuccessfulInstitutional leaders consider policies about late-career physicians (LCPs; physicians working beyond age 65 to 75 years) to be successful, according to a study published online Nov. 5 in the Annals of Internal Medicine.Noting that some health care organizations (HCOs) have adopted LCP policies requiring cognitive, physical, and practice |
HealthDay
04 November at 04.40 PM
New Set of Risk Factors Can Boost Detection of Suspicious Skin LesionsA new set of skin cancer risk factors can improve detection of suspicious skin lesions, according to a study published online Sept. 6 in Scientific Reports.Shafiqul Islam, Ph.D., from the University of Essex in Colchester, England, and colleagues examined artificial intelligence (AI) models that use patient metadata consisting of 23 attr |
MedScape
04 November at 07.12 AM
US FDA Approves Journey Medical's Drug for Long-term Skin ConditionJourney Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea, sending the... |
MedScape
04 November at 06.41 AM
Bimekizumab Offers Durable and Consistent Benefits in HSPatients with moderate to severe HS experienced sustained symptomatic and quality-of-life improvements with the monoclonal antibody bimekizumab, reveals 2-year trial data. |
MedScape
04 November at 04.48 AM
Questionnaire Helped Detect Depression in Patients With HSActions that clinicians took for patients who screened positive for depression included providing mental health resources and referrals for therapy. |
MedScape
04 November at 03.10 AM
HS Linked to Increased Risk for Eating DisordersAccording to the study’s lead author, the topic has not been explored previously. |
HealthDay
01 November at 03.51 PM
Uninsurance Plays Major Role in Racial Disparities Seen in Cancer DiagnosisLack of health insurance coverage accounts for a considerable proportion of racial and ethnic disparities in advanced-stage diagnoses of cancer, according to a study published online Oct. 30 in the Journal of the National Cancer Institute.Parichoy Pal Choudhury, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined |
MedScape
01 November at 10.00 AM
Dermatologists Sound Alarm as Scabies Cases RiseSurveillance data showed numbers "well above" the 5-year average, even ahead of the winter peak. |
MedScape
01 November at 07.56 AM
Cosmetic Dermatology Product Recalls Still CommonBetween 2011 and 2023, the FDA reported 334 voluntary recalls of cosmetic dermatology products, mostly because of microbial contamination, according to an analysis of an FDA database. |
HealthDay
31 October at 09.06 PM
First Cases of Sexually Transmitted Ringworm Reported in the U.S.Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm (Trichophyton mentagrophytes).Until now, transmission of the fungal infection through skin-to-skin sexual contact has been rare, although cases have been reported in Southeast Asia and France since 2021, researchers reported. These hav |
MedScape
31 October at 06.12 AM
Iberdomide Promising for Cutaneous Lupus in Phase 2 StudyIn a phase 2 trial, iberdomide was associated with improved symptoms when added to standard lupus medications in patients with subacute and chronic cutaneous lupus erythematosus |
HealthDay
30 October at 03.42 PM
Potential Genetic Link ID'd Between Thyroid Disease, Alopecia AreataThere seems to be a significant association between hypothyroidism, Hashimoto thyroiditis, subacute thyroiditis, and alopecia areata (AA), according to a study published in the October issue of Skin Research & Technology.Yue Zhao, from Heping Hospital Affiliated to Changzhi Medical College in China, and colleagues examined the po |
MedScape
28 October at 07.33 AM
US Veterans May Face Nearly Triple the Risk for Skin CancerResults were based on a study comparing 14,301 veterans with 209,936 nonveterans. |
MedScape
28 October at 04.15 AM
Study Compares Methods for Treating Recalcitrant KeloidsResearchers used the Vancouver Scar Scale (VSS) to assess treatment efficacy in 22 patients. |
MedScape
28 October at 03.53 AM
Upadacitinib Effective Long Term for AD in AdolescentsAn analysis of three phase 3 trials reported relief with upadacitinib through 76 weeks in adolescents with AD. |
HealthDay
25 October at 08.32 PM
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic DermatitisLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues evaluated the effi |
MedScape
25 October at 10.00 AM
Infant's Rash Defies Most Likely DiagnosesThe elusive but correct diagnosis proved to be a simple, easily treated condition. |
MedScape
25 October at 06.15 AM
OnabotulinumtoxinA Approved for Treatment of Platysma BandsThis marks the product’s fourth approved indication. |
HealthDay
24 October at 03.44 PM
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary AngioedemaFor adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9, administered as a single dose reduces angioedema attacks, according to a study published online Oct. 24 in the New England Journal of Medicine to |
MedScape
24 October at 03.17 PM
Emerging Fungal Infections Demand All-Out Approach“Trichophyton indotineae is changing the way we talk about dermatophyte infections,” said NYU dermatologist Avrom S. Caplan, MD. |
MedScape
24 October at 07.12 AM
A Dermatologist’s Tips for Supporting LGBTQ Youth“Gender-affirming care happens not only with medications but with communication, curiosity, and respect,” Boos said. |
HealthDay
23 October at 03.09 PM
FDA Appoints New Head of Medical DevicesThe U.S. Food and Drug Administration announced Tuesday that it has appointed Dr. Michelle Tarver to head its division that oversees medical devices.The appointment of a new director for the <a href="https://www.fda.gov/about-fda/fda-organization/center-devices-and-r |
MedScape
23 October at 05.36 AM
ICD-10-CM Codes Debut for Two Hair Loss DisordersThe new codes — L66.81 for CCCA and L66.12 for FFA — were implemented on October 1, 2024. |
MedScape
22 October at 06.20 AM
Alopecia Areata: Hair Growth Sustained With RitlecitinibUp to 100% of ritlecitinib responders sustained hair regrowth and 30% of nonresponders achieved results at week 48 with continuous treatment, according to a post hoc study analysis. |
MedScape
22 October at 03.53 AM
Photodynamic Therapy Found to Reduce Rhytides“The degree of improvement was impressive and not far off from those reported with CO2 ablative laser,” Luke Horton, MD, said. |
MedScape
21 October at 06.28 AM
Nemolizumab Reassures in Long-Term Atopic Dermatitis StudyAn interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of nemolizumab in patients with moderate to severe AD. |
MedScape
18 October at 09.28 AM
Ruxolitinib Cream Shows Promise in Treating Lichen PlanusA study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential treatment for cutaneous lichen planus that is also well tolerated. |
MedScape
18 October at 07.13 AM
No Excess MACE Risk for JAKis in Atopic Dermatitis AnalysisResults of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with upadacitinib and abrocitinib for atopic dermatitis. |
MedScape
18 October at 05.33 AM
Maternal HS Tied to Adverse Outcomes in Children and MothersMothers with HS and their children face higher risks for adverse outcomes at birth and long-term, a study found. |
MedScape
17 October at 09.07 AM
Facial Melasma Improves With New CosmeceuticalA new serum containing 2-mercaptonicotinoyl glycine as its main ingredient was at least as good as cysteamine 5% cream in treating facial melasma in a randomized study. |
MedScape
16 October at 06.10 AM
Children With Severe AD Catch Up on Growth With DupilumabEffective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on their growth, potentially offering lifelong benefits, according to the results of a study of children aged 6-11 years. |
MedScape
16 October at 05.33 AM
Genetic Link Found Between HS and Cardiometabolic DiseaseHS is associated with a genetic predisposition that may increase the risk for CAD and diabetes, driven by shared genetic factors and altered plasma proteomic profiles. |
MedScape
16 October at 04.39 AM
Antibody Levels Tied to Bullous Pemphigoid SeverityA meta-analysis of 14 studies found that serum levels of anti-BP180 autoantibody strongly correlated with the severity of bullous pemphigoid. |
MedScape
16 October at 12.56 AM
Study Finds Racial Differences in Second Primary MelanomaWhite patients have the highest incidence of second primary melanoma, while Black patients face the greatest relative risk, according to a study. |
HealthDay
15 October at 03.46 PM
Relationship Suggested Between Hyperhidrosis, Sensitive SkinSensitive skin (SS) seems to be associated with primary hyperhidrosis (PHH), according to a study published online Sept. 30 in the Journal of Drugs in Dermatology.Erika T. McCormick, from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colleagues surveyed 637 PHH sufferers to assess HH a |
HealthDay
11 October at 03.53 PM
Industry Payments Common for Physician Peer Reviewers of Top JournalsMore than half of U.S. physician peer reviewers for the most influential medical journals receive industry payments, according to a research letter published online Oct. 10 in the Journal of the American Medical Association.David-Dan Nguyen, M.P.H., from the University of Toronto, and colleagues characterized payments by drug and m |
HealthDay
11 October at 03.51 PM
Benzene Exposure Results From Benzoyl Peroxide Drug Product UsePotential benzene exposure occurs as a result of benzoyl peroxide (BPO) drug product use, according to a study published online Oct. 7 in the Journal of Investigative Dermatology.The carcinogen benzene is a degradation product of BPO and has been reported to form when BPO drug products are incubated at body temperature and elevated temp |
MedScape
11 October at 10.00 AM
Drug Bests Phototherapy for Severe Hand EczemaAlitretinoin netted a greater reduction in severity by 12 weeks, although differences were not significant thereafter. |
MedScape
10 October at 10.43 AM
Study Evaluates Safety of BPO Products for AcneOf 111 products tested, 34% contained benzene levels above the FDA limit of 2 ppm. |
MedScape
10 October at 09.50 AM
Pulsed Dye Laser an Option for Acne TreatmentIn a real-world study of PDL therapy in 15 adult women with recalcitrant acne, inflammatory and noninflammatory lesion counts were significantly reduced 3 months after treatment. |
MedScape
10 October at 05.17 AM
Epidermal Necrolysis Tied to 34% Mortality in French StudyEpidermal necrolysis was associated with high rates of inhospital and post-discharge mortality in a French cohort study. |
MedScape
10 October at 02.13 AM
AI Device Effectively Identifies Skin Lesions in Study"Its usage could decrease needless dermatology referrals and reduce patient concerns for malignancy," the study authors wrote. |
HealthDay
09 October at 10.18 PM
Risk for Second Melanoma Up for Those With First Melanoma DiagnosisPatients with a first melanoma diagnosis have an increased risk for a second melanoma diagnosis, regardless of race and ethnicity, according to a research letter published online Oct. 9 in JAMA Dermatology.Shoshana Zhang, from Dell Medical School at the University of Texas at Austin, and colleagues examined the absolute risk of second |
MedScape
09 October at 06.48 AM
Review Highlights GI Risks for Biologic Rxs for PsoriasisInterleukin-17 inhibitors showed a higher relative risk for GI events, in a review. |
MedScape
09 October at 05.49 AM
Late Dupilumab Responders Have Unique Molecular ProfileIn a major potential step toward personalized therapy for atopic dermatitis, data suggest early, late, and no clinical response to dupilumab can be differentiated on a molecular basis. |
MedScape
09 October at 04.00 AM
Methotrexate in Atopic Dermatitis: Experts Clarify DosageDermatology experts have created key recommendations to guide the standardized use of methotrexate for refractory atopic dermatitis. |
MedScape
08 October at 08.28 AM
Phase 3 Izokibep Study in HS Produces Promising ResultsThe investigational IL-17A inhibitor izokibep was found to induce clear clinical responses in people with moderate to severe HS within a few weeks of treatment. |
MedScape
08 October at 07.09 AM
Hand Eczema: Delgocitinib Takes on Established TreatmentsTopical delgocitinib appears more effective than oral alitretinoin and is comparable to dupilumab for treating types of hand eczema, according to two separate studies. |
HealthDay
07 October at 04.02 PM
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis SuppurativaFor patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Christos C. Zouboulis, from the European Hidradenitis Suppurativa Foundation in Dessau, Germany, and |
MedScape
07 October at 05.49 AM
New Drug Class for Prurigo Nodularis Moving ForwardTwo years after the first therapy for prurigo nodularis was approved, an oral drug in clinical trials provides a third mechanism of action for treating this disease. |
MedScape
07 October at 02.38 AM
Novel Treatment Alleviates Postherpetic NeuralgiaTwo different doses of crisugabalin resulted in significantly greater pain reductions in adults with postherpetic neuralgia than placebo in a phase 3 trial. |
MedScape
07 October at 02.12 AM
Study Describes Skin Conditions in Down SyndromeEczematous dermatitis was the most common skin condition diagnosed in patients with Down syndrome, according to a multicenter retrospective review. |
HealthDay
04 October at 03.27 PM
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe EczemaFor patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Diamant Thaçi, Ph.D., from University Lübeck in Germany, and colleagues reported long-term efficacy and |
MedScape
04 October at 07.55 AM
A Measured Approach Key to Treating Mycosis FungoidesTopical/skin directed therapies are best for early-stage disease or in combination with systemic therapies in advanced disease, according to Dr Arron Mangold. |
MedScape
04 October at 07.20 AM
Molecular Effects of Investigational AD Treatment DescribedBy blocking IL-22 in keratinocytes, temtokibart normalizes the skin barrier and boosts hydration, suggested a study of gene expression changes in the skin. |
MedScape
03 October at 08.42 AM
Topical JAK inhibitor Provides Sustained Control of HSRuxolitinib cream applied on an as-needed basis provided sustained clearance of hidradenitis suppurativa nodules during the open-label extension of a phase 2 trial. |
MedScape
03 October at 08.15 AM
Cancer Screening Guidelines Validated for DermatomyositisMost of the cancers were detected using standard age- and sex-based cancer screenings, suggesting the potential for overscreening in this population. |
MedScape
03 October at 06.44 AM
Study Supports Use of Home-Based Phototherapy for PsoriasisHome-based phototherapy for plaque and guttate psoriasis is as effective as office-based phototherapy, results of the randomized Light Treatment Effectiveness study found. |
HealthDay
02 October at 09.56 PM
Female Residents Underrepresented in High-Compensation SpecialtiesFemale physicians remain underrepresented among residents entering high-compensation specialties, according to a research letter published online Sept. 30 in the Journal of the American Medical Association.Karina Pereira-Lima, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined national trends in the prop |
HealthDay
02 October at 03.04 PM
Anti-CTAg Antibodies Identified in Stage I, II MelanomaCirculating antibodies against cancer-testis antigens (CTAgs) are found in stage I and stage II melanoma plasma samples, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Cristina Vico-Alonso, M.D., from Monash University Public Health and Preventi |
MedScape
02 October at 10.17 AM
HS Symptoms Eased by Semaglutide-Aided Weight LossImprovements in the Dermatology Life Quality Index score and hidradenitis suppurativa flares were seen in people who achieved semaglutide-induced weight loss. |
MedScape
02 October at 08.49 AM
Topical JAKi Shows Promise for Frontal Fibrosing AlopeciaIn a small randomized, controlled trial of patients with FFA with an open-label extension at 12 weeks, symptoms of moderate to severe frontal fibrosing alopecia improved with topical delgocitinib. |
MedScape
01 October at 08.10 AM
Durable Responses Seen With Barzolvolimab in CSU TrialPatients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who remained in the phase 2 trial. |
MedScape
01 October at 02.58 AM
Delgocitinib Approved in Europe for Chronic Hand EczemaDelgocitinib is also under FDA review for the same indication in the United States. |
HealthDay
30 September at 03.48 PM
Home-Based Phototherapy as Effective as Office-Based for PsoriasisFor plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept. 25 in JAMA Dermatology to coincide with the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Joel M. Gelf |
MedScape
30 September at 07.21 AM
Atopic Dermatitis Control on Biologic Persists Over 3 YearsIn a 3-year extension of the pivotal trials that provided lebrikizumab with an indication for atopic dermatitis, the response at 12 months remained about the same at 3 years. |
MedScape
30 September at 05.40 AM
Some Aspects of the Skin Microbiome Remain ElusiveFactors that influence the skin microbiome include genetics, climate, pollution, and hygiene practices, as well as age. |
MedScape
27 September at 07.08 AM
Eczema Starting in Childhood Adds Burden in AdulthoodWhen childhood atopic dermatitis persists into adulthood, the large reduction in quality of life suggests that the price of inadequate control in children is high. |
MedScape
27 September at 02.08 AM
Resistance Trends for S aureus in Atopic DermatitisSignificant differences are seen in antimicrobial susceptibility between high-income and middle-income countries. |
HealthDay
26 September at 03.44 PM
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid CancerPatients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck, according to a study published online Sept. 19 in JAMA Network Open.Shawheen J. Rezaei, from the Stanford University School of Medici |
HealthDay
25 September at 03.40 PM
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With ObesityFor patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Daniel Lyons, M.D., fro |
MedScape
24 September at 08.29 AM
Atypical CCCA Hair Loss Remains UnderappreciatedDelayed diagnosis and treatment of CCCA result in insufficiently aggressive therapy and risks an avoidable consequence, irreversible hair loss. |
HealthDay
19 September at 03.31 PM
Long-Term Survival Benefit Seen for Nivolumab in Advanced MelanomaFor patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy, according to a study published online Sept. 15 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from S |
MedScape
19 September at 04.51 AM
Roflumilast Cream Effective for AD in Phase 3 StudiesTreatment with roflumilast cream 0.15% once daily improved mild to moderate AD in two phase 3 randomized clinical trials of children 6 years or older and adults. |
MedScape
19 September at 02.39 AM
Drug-Induced Rashes in Skin of Color: Diagnostic ChallengesThe risks, appearance, and consequences for drug-induced rashes often differ in patients with skin of color, further complicating an already challenging diagnosis. |
HealthDay
18 September at 10.22 PM
FDA Approves Ebglyss for Moderate-to-Severe Atopic DermatitisThe U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.The targeted interleukin-13 inhibitor is administered via a 250-mg/2 mL injection with or without topical corticosteroids in patients with atopic dermatitis not well controll |
MedScape
18 September at 11.00 AM
Study finds early puberty linked to higher risk for HSThe prevalence of precocious puberty was higher among children with hidradenitis suppurativa in a case-control study. |
MedScape
18 September at 05.46 AM
Seborrheic Dermatitis Progress Meaningful for Skin of ColorNow that there is an approved therapy for seborrheic dermatitis, it is time to give this condition the attention and respect it deserves across races and ethnicities. |
MedScape
18 September at 05.36 AM
Pivotal Trials Will Address Diversity With New FDA InitiativeExpected sometime in 2025, details on plans for enrollment by race, ethnicity, age, and sex will be required for all pivotal and phase 3 trials, according to a new FDA initiative. |
MedScape
18 September at 01.44 AM
Biomarkers in Cord Blood May Predict AD in NewbornsBlood serum levels of CCL17/TARC and IL-31 and transepidermal water loss were predictive markers for atopic dermatitis in a prospective observational study of newborns. |
HealthDay
17 September at 02.52 PM
Study Looks at Sex Differences in Melanoma IncidenceMelanoma rates differ for men and women, including in terms of ages of occurrence and locations of melanoma, according to a study published online June 17 in the Journal of Investigative Dermatology.Catherine M. Olsen, Ph.D., from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and colleagues analyzed long-term m |
MedScape
17 September at 04.57 AM
Is Obesity Linked to Pediatric Hidradenitis Suppurativa?About 42% of pediatric patients with HS had obesity, in a scoping review of 12 studies. |
MedScape
16 September at 08.11 AM
Expert Highlights Two Novel Drugs for EczemaThe current pipeline includes 49 topical and 39 injectable medicines. |
MedScape
14 September at 09.59 AM
FDA Approves Lebrikizumab for Atopic DermatitisMore than 1000 people age 12 years and older were enrolled in pivotal trials of the IL-13 inhibitor. |
MedScape
13 September at 10.00 AM
Psoriasis: Will It Progress to Arthritis?In a primary care population, the annual incidence of progression was low during the first few years of follow-up. |
MedScape
13 September at 05.48 AM
Consensus Defines Key Aspects of Atopic Dermatitis FlaresA study developed a patient-centered definition of atopic dermatitis through consensus. |
MedScape
12 September at 08.51 AM
Expert Warns of AI Pitfalls in Dermatology"These models are not appropriate to use for patient care," Roxana Daneshjou, MD, PhD, said. |
MedScape
12 September at 03.13 AM
Study Reports Safety Data in Children on JAK InhibitorsThe most frequently reported adverse events in children on a JAK inhibitor were blood and lymphatic system disorders, in a review of FDA and Canadian adverse event reports. |
MedScape
11 September at 08.42 AM
Imaging Technique Reveals Key Features of Nail DiseasesNailfold capillaroscopy may serve as a quick, cost-effective, and noninvasive tool to aid in the diagnosis and management of nail disorders. |
HealthDay
10 September at 04.15 PM
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 YearsFor adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study published online Sept. 8 in JAMA Dermatology to coincide with the annual meeting of the European Society for Medical Oncology, held from Sept. 13 to 17 in Barcelona, Spain.Hildur Helgadottir, M.D., Ph.D., from the Karolin |
HealthDay
09 September at 03.33 PM
Skin Care Product Use by Children Tied to Phthalates/Replacement MetabolitesIn young children, skin care product (SCP) use is associated with urinary phthalate/replacement metabolites, according to a study published online Sept. 4 in Environmental Health Perspectives.Michael S. Bloom, Ph.D., from George Mason University in Fairfax, Virginia, and colleagues examined the associations between SCP use and children' |
MedScape
06 September at 04.21 PM
Not Kidding: Yellow Dye 5 May Be the Key to InvisibilityA common food dye turned mice see-through, a "stunning" finding that could revolutionize imaging techniques in medicine. |
MedScape
06 September at 10.10 AM
Vitiligo: Combination Therapies and Emerging TreatmentsIt can take up to 1 year to see a significant response with topical immunosuppressants and narrowband ultraviolet B treatment. |
MedScape
06 September at 09.06 AM
Metformin May Help Manage Scarring Alopecia, Study SuggestsLow-dose oral metformin was associated with symptomatic improvement, hair regrowth, and gene expression modulation in a case series of patients with treatment-refractory central centrifugal cicatricial alopecia. |
MedScape
05 September at 09.33 AM
Study Finds Skin Cancer Risk Increased in US VeteransThe risk for any skin cancer was higher among US veterans than among nonveterans, according to a cross-sectional study using nationally representative data collected over 20 years. |
MedScape
05 September at 02.48 AM
How Do Tapinarof, Roflumilast Creams Fit Into Psoriasis Rx?Both nonsteroidal options are fast-acting, Jashin J. Wu said. |
HealthDay
04 September at 03.03 PM
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 GenotypeThe association of prenatal ω-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) with the risk for childhood atopic dermatitis (AD) varies based on the maternal cyclooxygenase-1 (COX1) genotype, according to a study published online Aug. 28 in JAMA Dermatology.Liang Chen, from Herlev and Gentofte Hospital in Copenhagen, Denmark, an |
MedScape
04 September at 05.35 AM
Study Characterizes Skin Toxicity With Uveal Melanoma RxNearly 80% of patients with uveal melanoma treated with tebentafusp experienced skin reactions in a small cohort study. |
MedScape
04 September at 03.17 AM
Topical Timolol an Option for Treating Pyogenic GranulomaSeveral case reports about the use of topical timolol for PG have been published in the medical literature, including a case series. |
HealthDay
03 September at 08.05 PM
Global Study Reveals Widespread Micronutrient DeficienciesMore than 5 billion people globally do not consume enough iodine, vitamin E, and calcium, according to a study published online Aug. 29 in The Lancet Global Health.Simone Passarelli, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated micronutrient intake using a novel approach accounting for t |
MedScape
02 September at 09.11 AM
Study Assesses Childhood Cancer Survivors' Risk for KCsThis study "provides the largest longitudinal profile" of keratinocyte carcinomas in childhood cancer survivors to date, according to the authors. |
MedScape
02 September at 08.43 AM
Can Prenatal Fish Oil Reduce AD Risk in Children?The mother's COX1 genotype could influence whether prenatal fish oil supplementation affects the risk for atopic dermatitis in children, a study found. |
MedScape
02 September at 04.21 AM
Vitiligo Linked to Psychiatric Conditions in Black ChildrenA study found a significantly higher risk for several psychiatric disorders in Black children with vitiligo. |
HealthDay
30 August at 03.06 PM
Dietary Vitamin E May Be Protective Against Atopic DermatitisDietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in Skin Research & Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary |
MedScape
30 August at 02.38 AM
Impact of Neurofibromatosis on Quality of Life EvaluatedA crowdsourced registry study found associations between features of cutaneous neurofibromas and quality of life in patients with neurofibromatosis type 1. |
MedScape
30 August at 01.40 AM
Laser Treatment for Acne: Results From 100 PatientsThe protocol included three laser treatments spaced 3-4 weeks apart combined with medical therapy and other energy-based devices. |
HealthDay
29 August at 03.46 PM
People With Xylazine Wounds Face Barriers to Seeking Wound CarePeople with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und |
HealthDay
27 August at 09.50 PM
Team-Based Documentation Can Increase Visit Volume, Cut Documentation TimePhysicians who adopt team-based documentation, defined as use of coauthored documentation with another clinical team member, experience increased visit volume and reduced documentation time, according to a study published online Aug. 26 in JAMA Internal Medicine.Nate C. Apathy, Ph.D., from the University of Maryland School of Public He |
HealthDay
27 August at 03.52 PM
Childhood Obesity Tied to Pediatric Immune-Mediated Skin DiseasesEarly childhood obesity may increase the risk for pediatric immune-mediated skin diseases, according to a study published online Aug. 21 in the Journal of Investigative Dermatology.Seong Rae Kim, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined associations between body mass inde |
MedScape
26 August at 07.36 AM
iPLEDGE Reforms: Are Changes Imminent? Timeline UnclearThe timeline for when an improved program might be in place remains unclear. |
MedScape
26 August at 06.44 AM
TYK2 Inhibitor Shows Promise for Moderate, Severe PsoriasisZasocitinib showed significant efficacy in treating moderate to severe psoriasis, with 67%-68% of patients on higher doses achieving a PASI 75 score at 12 weeks. |
MedScape
22 August at 11.33 PM
Quitting Smoking Reduces HS Risk After 3 YearsSmoking cessation reduced the risk for hidradenitis suppurativa, eventually aligning with the risk for never smokers. |
HealthDay
22 August at 09.33 AM
Americans Have Mixed Feelings About AI in Health Care, Poll FindsMost Americans believe artificial intelligence should be used to improve health care, a new national survey reports.However, many are still a little queasy over some of the implications of widespread AI use, the <a href="https://wexnermedical.osu |
HealthDay
21 August at 03.11 PM
Collagen Peptide Beverage Beneficial for Skin Health in Young WomenA beverage containing collagen peptides (CP), including tripeptides and elastin peptides (EP), is beneficial for the skin health of young and middle-aged women, according to a study published in the June issue of the Journal of Dermatologic Science and Cosmetic Technology.Shan Lu, from the Shenzhen Porshealth Bioengineering Co. in Ch |
MedScape
21 August at 12.26 PM
Laser Treatment of Nonmelanoma Skin Cancer on the RiseA seminal study from 2017 laid the groundwork for current approaches, Elizabeth Tanzi, MD, said. |
MedScape
20 August at 05.00 AM
Dermatologist Offers Best Practices for Social Media PostsDeciding which platforms to use and what voice or tone to adopt requires some soul-searching, according to Jessica G. Labadie, MD. |
MedScape
19 August at 06.04 AM
Who's Performing Cosmetic Procedures at MedSpas?The top two procedures performed by the surveyed MedSpas are facials and hair removal. |
HealthDay
16 August at 09.21 PM
Skin of Color Has More Adverse Events From SclerotherapyPatients with skin of color may experience more adverse events from sclerotherapy, according to a study published online July 26 in the Journal of the American Academy of Dermatology.Michelle Lazar, from the Boston University School of Medicine, and colleagues characterized the incidence of common adverse events following sclerothe |
MedScape
16 August at 07.49 AM
Managing Orofacial Changes in SclerodermaThe recommended treatment for patients with scleroderma was to use nerve blocks for injecting HA filler or hyaluronidase and to minimize the injection points. |
HealthDay
15 August at 10.00 PM
FDA Approves Nemluvio for Prurigo NodularisThe U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi |
HealthDay
14 August at 03.45 PM
Clinicians Are Interested in Climate Change EducationMost clinicians show positive attitudes toward education in climate change, according to a study published online Aug. 8 in JAMA Network Open.Wynne Armand, M.D., from the Center for the Environment and Health at Massachusetts General Hospital in Boston, and colleagues evaluated whether a quality incentive program measure for cli |
MedScape
14 August at 11.00 AM
Dermatomyositis: Age at Dx, Signs Differ in HispanicsA study identified distinct clinical features and other differences in Hispanic patients with dermatomyositis compared with non-Hispanic patients. |
MedScape
14 August at 11.00 AM
Alopecia: What Happens When Baricitinib Responders Stop Rx?Continuous treatment with baricitinib is needed to maintain hair regrowth in patients with severe alopecia areata. |
MedScape
13 August at 11.30 AM
FDA Approves Nemolizumab for Prurigo NodularisThe interleukin-31 inhibitor is also under FDA review for treating atopic dermatitis. |
MedScape
13 August at 08.21 AM
Recommendations on Managing Cutaneous Side Effects of ICIsCutaneous immune-related adverse events (cirAEs) are the most frequently reported and most visible adverse effects of checkpoint inhibition. |
HealthDay
12 August at 03.54 PM
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With EczemaFor patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini |
HealthDay
12 August at 03.47 PM
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma PatientsA gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in |
HealthDay
12 August at 03.44 PM
Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug ReactionsSulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w |
HealthDay
09 August at 03.37 PM
Racial Differences Identified in Frequency of Biopsy for PsoriasisThere are racial differences in the frequency of skin biopsy for psoriasis, indicating diagnostic uncertainty, according to a research letter published online Aug. 7 in JAMA Dermatology.Fahad Ahmed, from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a cross-sectional study inv |
HealthDay
08 August at 03.42 PM
ChatGPT Only Gets Diagnoses Correct Half of the TimeChatGPT is not accurate as a diagnostic tool, but does offer some medical educational benefits, according to a study published online July 31 in PLOS ONE.Ali Hadi, from the Schulich School of Medicine and Dentistry at Western University in London, Ontario, Canada, and colleagues investigated ChatGPT’s diagnostic accuracy and utili |
HealthDay
08 August at 11.41 AM
New Strain of Mpox Spreading in Africa Has CDC ConcernedU.S. doctors should be on the lookout for a more severe strain of mpox that is spreading widely in parts of Africa, federal health officials warned Wednesday.The alert, issued by the U.S. Centers for Disease Control and Prevention, came just hours after the World Health Org |
HealthDay
06 August at 11.04 PM
Alopecia Tied to Higher Prevalence of Autoimmune, Psychiatric ComorbiditiesPatients with alopecia areata (AA) have a higher prevalence of autoimmune and psychiatric comorbidities at time of diagnosis as well as a higher risk for new-onset autoimmune and psychiatric comorbidities after diagnosis, according to a study published online July 31 in JAMA Dermatology.Arash Mostaghimi, M.D., M.P.H., from Brigham |
HealthDay
02 August at 10.52 PM
FDA Approves Leqselvi for Severe AlopeciaThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was |
HealthDay
01 August at 09.37 PM
FDA Warns Against Using Chemical Peels Without Professional SupervisionThe U.S. Food and Drug Administration is warning that chemical peels should not be used without the supervision of a dermatologist or other trained professional."FDA is warning consumers not to purchase or use certain chemical peel skin products without appropriate professional supervision due to risk of serious skin injuries," the agency said |
HealthDay
01 August at 04.11 PM
CDC Report Addresses Nonfinancial Access Barriers to Care in 2022Nonfinancial access barriers to care represent a persistent problem in the United States, with more than 12 percent of adults reporting being too busy to go to a provider, according to a study published online Aug. 1 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.Amanda E. N |
HealthDay
01 August at 03.59 PM
Relatively High Frequency of Emergency Complications Seen for Dermatological ProceduresA relatively high proportion of dermatologists experience emergency complications during dermatological, surgical, or cosmetic procedures, according to a study published online July 20 in the Journal of Cosmetic Dermatology.Hilal Kaya Erdogan, M.D., from Eskişehir Osmangazi University in Turkey, and colleagues conducted a cross-section |
HealthDay
30 July at 08.54 PM
Gen Z Perceives Atopic Dermatitis to Be More SevereGeneration Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published online July 25 in the International Journal of Dermatology.Clara Ureña-Paniego, from the University of Granada in Spain, and colleagues compared the clinical se |
HealthDay
29 July at 07.12 PM
Atopic Dermatitis Has Large Impact on Sexual Function Among WomenMost women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a study published online June 11 in Acta Dermato-Venereologica.Juan-Angel Rodriguez-Pozo, from the Virgen de las Nieves University Hospital in Granada, Spain, and coll |
HealthDay
29 July at 03.30 PM
Psoriasis, Psoriatic Arthritis Tied to Higher Risk of PolyneuropathyPsoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve.Pietro E. Doneddu, M.D., from the IRCCS Humanitas Research Hospital in Milan, and colleagues evaluated the risk and features of peripheral neuropathy in patients with psor |
HealthDay
26 July at 03.50 PM
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen SclerosusHydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog |
HealthDay
24 July at 03.23 PM
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for EczemaUse of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee |
HealthDay
19 July at 10.52 PM
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual AdultsWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published online July 17 in JAMA Dermatology.Katelyn J. Rypka, from the University of Minnesota in Minneapolis, and colleagues examined differences in the lifetime |
HealthDay
19 July at 03.42 PM
Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun ClimateTo achieve maximal paralysis, patients injected with glabellar botulinum toxin may have significantly higher dose requirements in a high sun-exposure environment, according to a study published in the July issue of Plastic and Reconstructive Surgery.Kim L. Borsky, M.B.B.S., M.D., from the Stoke Mandeville Hospital in the United Kingdom, |
HealthDay
18 July at 04.04 PM
Air Pollution Exposure Tied to New PsoriasisLong-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open.Junhui Wu, Ph.D., from the Peking University School of Nursing in Beijing, and colleagues examined the association between long-term exposure to air pollution and psoriasis an |
HealthDay
16 July at 10.52 PM
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With MigraineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris |
HealthDay
12 July at 10.23 PM
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox InjectionsSeven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact |
HealthDay
12 July at 10.21 PM
More Women Than Men Experience Nonphysical Violence in Health Care WorkforceWomen in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin |
HealthDay
11 July at 10.11 PM
FDA Approves Zoryve for Atopic DermatitisThe U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu |
HealthDay
10 July at 04.06 PM
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in AcneAdherence to a Mediterranean diet incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces skin lesions and improves quality of life in patients with acne, according to a study published online July 10 in the Journal of Cosmetic Dermatology.Anne Guertler, M.D., from Ludwig Maximilian University in Munich, and |
HealthDay
09 July at 03.45 PM
Rural Residents Continue to Have Higher Odds of Skin CancerUrban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology.Rachel R. Lin, from the University of Miami Miller School of Medicine, and colleagues used data from the Behavior Risk Factor Surveillance Survey (2018 to 2021) to compare th |
HealthDay
05 July at 02.26 PM
Postpandemic Physician Revenue Recovery Varies by Specialty, Practice TypePandemic-associated physician revenue recovery in 2021 and 2022 varied by specialty and practice type, according to a study published in the July issue of Health Affairs.Ravi B. Parikh, M.D., from the University of Pennsylvania in Philadelphia, and colleagues assessed pandemic-related impact on physician revenue (2020 to 2022) and h |
HealthDay
02 July at 04.01 PM
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 MillionThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass |
HealthDay
01 July at 03.16 PM
Psoriasis, With or Without Psoriatic Arthritis, Associated With FatiguePsoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and it |
HealthDay
01 July at 03.04 PM
Few Patients With Positive Margins After Basal Cell Excision Have RecurrenceAmong patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of |
HealthDay
25 June at 09.42 PM
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusFor patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine |
HealthDay
24 June at 03.02 PM
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in MelanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random |
HealthDay
20 June at 08.56 PM
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 MonthsFrom 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil |
HealthDay
18 June at 09.11 PM
Approximately 7 Percent of U.S. Population Uninsured in 2023In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from |
HealthDay
18 June at 03.44 PM
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment EffectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive |
HealthDay
18 June at 09.50 AM
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to ExpireIn a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h |
HealthDay
14 June at 03.32 PM
No Evidence That Live Vaccines Are Unsafe for Patients on DupilumabThere is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma & Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub |
HealthDay
13 June at 10.58 PM
Health Care Spending Growth Projected to Outpace GDP to 2032Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected growth in national health expend |
HealthDay
12 June at 03.05 PM
Adverse Effects of Medical Treatment Increasing WorldwideThe burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality & Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences & Peking University Medical Col |
HealthDay
07 June at 03.33 PM
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming TherapyIsotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen |
HealthDay
06 June at 10.28 PM
CDC Urges Clinicians to Remain on the Lookout for Mpox Virus InfectionsAmong emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Carl T. Berdahl, M.D., from Cedars-Sinai Medical Center in Los Angeles, and co |
HealthDay
05 June at 03.28 PM
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable MelanomaNeoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc |
HealthDay
03 June at 09.12 PM
9.6 Percent of Medical Visits Took Place Via Telehealth in 2021In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te |
HealthDay
31 May at 03.46 PM
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With EczemaLong-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of Clinical Dermatology.Lawrence F. Eichenfield, M.D., from the University of California San Diego, and colleagues asse |
HealthDay
30 May at 04.04 PM
Bimekizumab Yields Meaningful Response in Hidradenitis SuppurativaBimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b |
MedScape
30 May at 07.18 AM
Most Chronic Wounds Not Managed by Dermatologists"By examining national trends in patient visits and treatment, we may be able to better inform healthcare utilization for cutaneous wounds," Chandy said. |
MedScape
30 May at 06.51 AM
Psoriasis Tied to Increased Risk for MACE Despite Statin UseThe finding "highlights the need for further research into tailored treatments for cardiovascular risk in psoriasis patients," Ana Ormaza Vera said. |
MedScape
29 May at 11.10 PM
Study Addresses Racial/Ethnic Disparities in Psoriasis RxBlack patients with psoriasis had the lowest rate of switching to another biologic therapy compared with other racial and ethnic groups, suggesting possible disparities in treatment patterns. |
HealthDay
29 May at 09.17 PM
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care SpendingFrom 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro |
MedScape
29 May at 03.36 AM
Dupilumab: Future Treatment for Pediatric Alopecia Areata?Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia. |
MedScape
29 May at 03.07 AM
Tapinarof Cream Effective For AD, Down to Age 2 YearsResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old. |
HealthDay
28 May at 03.08 PM
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic DermatitisParental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA Dermatology.Gun Min Youn, from the Stanford University School of Medicine in California, and colleagues conducted a retrospective cross-sectional analysis of the 2014 to |
MedScape
27 May at 03.26 AM
Parental e-Cigarette Use May Increase AD Risk in ChildrenParental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a retrospective, cross-sectional analysis of US population data. |
MedScape
27 May at 02.51 AM
Eczema Risk Increased in Older Adults on AntihypertensivesUse of antihypertensive drugs was associated with a small increase in the rate of eczematous dermatitis diagnoses in older adults, with varying risks with different classes. |
HealthDay
24 May at 04.06 PM
Antihypertensives Linked to Eczematous Dermatitis in SeniorsAntihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine |
MedScape
24 May at 06.28 AM
Study Reveals Diverse Skin Manifestations in HemochromatosisAn iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, can help diagnose hemochromatosis. |
MedScape
23 May at 06.32 AM
High-Stage cSCC: Outcomes Superior With Mohs vs WLE"Our hope is that these findings provide additional data to support Mohs as the standard of care for primary surgical treatment of high-stage cSCC," the study's lead author said. |
HealthDay
22 May at 03.50 PM
Global Life Expectancy, Disease Burden Set to Keep ImprovingLife expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a |
MedScape
22 May at 11.00 AM
Top Tools for Measuring AD in Clinical Practice RecommendedConsensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds. |
MedScape
22 May at 04.53 AM
Home Phototherapy for Psoriasis: Optimizing AccessThe ideal candidate "is averse to using systemic agents but whose disease is beyond the point where topical medicines alone will work," Craig A. Elmets, MD, said. |
HealthDay
21 May at 10.56 PM
Acrochordons May Be Marker for Metabolic Disease in ChildrenIn pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 20 |
MedScape
20 May at 11.57 PM
Study Finds Radiotherapy for NMSC in Dermatology GrowingThere is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists. |
HealthDay
20 May at 03.58 PM
Individuals With BAP1 Have High Rate of Nail AbnormalitiesIndividuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.Alexandra Lebensohn, from the Nat |
MedScape
20 May at 03.03 AM
Chart Review Highlights Unique AD Features in Older PatientsMore research is "needed to elucidate the unique features of elderly AD in pathophysiology and optimal treatments," the study authors wrote. |
MedScape
19 May at 11.07 PM
Study Identifies Several Onychomycosis Risk FactorsTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in patients with onychodystrophy. |
MedScape
16 May at 09.26 AM
Skin Tags Linked to Metabolic Syndrome in ChildrenAcrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases. |
MedScape
16 May at 09.23 AM
Wits of Pediatric Dermatologists Pitted Against ChatGPTOverall, version 4.0 of the AI tool performed better than version 3.5. |
MedScape
16 May at 05.10 AM
Tranexamic Acid Injection Reduces Bleeding After MohsAdverse effects associated with using the antifibrinolytic were rare. |
HealthDay
15 May at 07.29 PM
Non-Hispanic Black Melanoma Patients Present With Advanced DiseaseNon-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study published in the May issue of the Journal of Surgical Oncology.Jessica A. Steadman, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined fe |
HealthDay
15 May at 03.45 PM
AACR Delivers Report on Disparities in Cancer ProgressIn its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un |
MedScape
14 May at 10.13 AM
US Study Delves Into Risk Factors for MelasmaExposure to hormones, hyperpigmenting drugs, and multiparity increased risk for melasma across different racial groups in a US study of a diverse population. |
HealthDay
13 May at 10.34 PM
Physicians With Disabilities May Experience DepersonalizationPhysicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb |
HealthDay
13 May at 03.50 PM
Study Identifies Factors Associated With Hydroxychloroquine RetinopathyFactors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or greater, according to a study published online May 9 in JAMA Network Open.April M. Jorge, M.D., from Massachusetts General Hospital in Boston, and colleagues identified |
HealthDay
13 May at 03.46 PM
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment InsightsPsoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment, according to a study published online April 17 in the Journal of Personalized Medicine.Georgiana Strugariu, from "Grigore T. Popa" University of Medicine and Phar |
MedScape
13 May at 09.58 AM
Patient Preferences Drive Treatment Options for Early HSMost ongoing trials of HS treatments are for moderate to severe disease, Dr Jennifer L. Hsiao said. |
MedScape
13 May at 08.59 AM
Reimbursement Rates for Mohs Surgery Lag Behind InflationHealthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates. |
MedScape
13 May at 07.29 AM
Experts Share Practical Tips for Diagnosing Mild HS"Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections," Sayed said. |
MedScape
13 May at 06.18 AM
Kids With Skin Diseases Face Stigma, Reduced Quality of LifePhysicians' assessment of disease severity and visibility may underestimate the disease's effects on the patient, data suggested. |
HealthDay
10 May at 12.42 PM
Cyberattack Cripples Major U.S. Health Care NetworkAscension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid |
MedScape
10 May at 06.19 AM
Immunosuppression Risk Factor for Poor cSCC OutcomesIn contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes. |
MedScape
09 May at 08.55 AM
Adalimumab Improves Blood Parameters in Patients With HSTreatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders. |
MedScape
09 May at 08.47 AM
SDM in Pediatric Dermatology: Step Approach RecommendedA pediatric dermatologist proposes a four-step approach to using shared decision-making (SDM) when caring for children and adolescent patients with acne and other skin conditions. |
MedScape
09 May at 06.33 AM
Evidence Accumulating on Viral Cause of Cutaneous GranulomasOf the cases accruing in the United States and elsewhere, most but not all were linked to inborn errors of immunity. |
HealthDay
08 May at 03.29 PM
Trifarotene Plus Skin Care Beneficial for Acne VulgarisTrifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medical College in New York City, and colleagues conducted a phase IV |
HealthDay
08 May at 03.07 PM
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis RiskSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the Journal of Allergy and Clinical Immunology.Courtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues e |
MedScape
08 May at 04.39 AM
IPC Develops Consensus on Generalized Pustular PsoriasisThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical considerations to speed treatment of this potentially life-threatening condition. |
MedScape
07 May at 08.28 AM
Many Drugs Linked to Pediatric SJS-TEN, WHO Data ShowAntiepileptic and anti-infectious agents were the most common classes tied to SJS-TEN. |
MedScape
07 May at 05.02 AM
Some Patients More Likely to Get Opioids After Mohs SurgeryCertain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use. |
MedScape
07 May at 04.19 AM
Rates of Emotional and Physical Stress High in Mohs SurgeonsAlmost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury. |
MedScape
06 May at 03.58 AM
Correct Dx of Cancer Treatment Skin Effects EvaluatedThe survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions. |
MedScape
06 May at 03.35 AM
Review Addresses Skin Manifestations of Cystic FibrosisA review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF. |
MedScape
06 May at 12.01 AM
Many Patients With Advanced MCC Not Receiving ImmunotherapyDespite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy. |
HealthDay
02 May at 03.37 PM
Algorithm From EHR Can ID Common Variable Immunodeficiency DiseaseA machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and tre |
MedScape
02 May at 07.17 AM
Mpox Presentation Compared in Racial, Ethnic GroupsA retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color. |
MedScape
02 May at 07.10 AM
ILD Not Increased With MTX in Patients With DermatomyositisTreatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis. |
HealthDay
30 April at 04.12 PM
Stigma Affects Quality of Life in Children With Chronic Skin ConditionsHealth care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and col |
MedScape
30 April at 09.07 AM
Heat-Based Wrinkle Treatment Holds up With Facial AnesthesiaSurface anesthesia prior to thermomechanical fractional injury therapy for wrinkles around the eyes provided adequate comfort, with positive treatment outcomes, a small study found. |
MedScape
30 April at 03.39 AM
Tapinarof Cream for Adult, Pediatric Eczema Under FDA ReviewA decision on approval is expected in the fourth quarter of 2024. |
MedScape
29 April at 05.54 AM
Children With Chronic Skin Disorders Face Substantial StigmaHealthcare professionals should be aware of the possibility of stigmatization and bullying when assessing the social and mental health of children and adolescents with chronic skin disorders. |
MedScape
26 April at 07.49 AM
Prurigo Nodularis Associated With Elevated CV Risks"The potential risk of subsequent cardiovascular disease should be considered in the care of patients with PN," according to the study authors. |
MedScape
25 April at 09.28 AM
FDA Seeks More Information About RDEB Rx Under ReviewPz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds. |
HealthDay
24 April at 07.53 PM
Tobacco Smoking Reduces the Odds of Psoriasis ImprovementTobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The |
MedScape
24 April at 03.16 AM
Erenumab Reduces Flushing and Erythema in RosaceaA calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea. |
HealthDay
23 April at 03.53 PM
Atopic Dermatitis Negatively Impacts Mental HealthAtopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in Dermatitis.Jessica K. Johnson, M.P.H., from the National Eczema Association in San Rafael, California, and colleagues evaluated patient-reported MH symptoms and their c |
MedScape
22 April at 08.32 AM
Hair Loss: Experts Provide Recommendations on Oral MinoxidilThe authors "identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients." |
MedScape
22 April at 06.12 AM
Neuromodulators: Rapid-Onset Option, Other Emerging TrendsExpect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says. |
MedScape
22 April at 03.32 AM
Study Shows Faster Recovery, Less Pain With 2910-nm LaserA small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers. |
MedScape
22 April at 03.22 AM
Does AD Severity Affect Growth in Children?An analysis evaluated growth in a study of 1326 children with AD younger than 12 years. |
HealthDay
19 April at 03.41 PM
Review Explores Cutaneous Manifestations of Myelodysplastic SyndromeCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.Xiang Li Tan, M.B.B.S., from St. George's University Hospitals NHS Foundation Trust in London, and colleagues conducted a systematic review to examine the prevalence, types, and prognos |
MedScape
19 April at 08.52 AM
Less PIH After Modified Laser Rx for Lentigines ReportedA 532-nm picosecond laser with fractional-beam microlens array to treat solar lentigines resulted in a lower hyperpigmentation rate in patients with darker skin types, vs the full-beam approach. |
MedScape
19 April at 04.58 AM
Registry Gives Snapshot of Cosmetic Procedure-Related AEsA registry of adverse events from dermatologic procedures found that blistering, hypopigmentation, scars, and burns are the most common complications from laser and energy devices. |
MedScape
18 April at 06.44 AM
Laser, Light Treatments Effective for PCOS-Related HirsutismLaser and light hair treatments, with and without other treatments, improve hirsutism and related psychological measures in women with PCOS. |
MedScape
18 April at 02.59 AM
Weekly Laser Treatment Promising for Port-Wine BirthmarksOnce-weekly PDL treatment in infants led to near-total or total clearance of PWB and was well-tolerated in 10 infants, suggesting further investigation of the reduced treatment interval of 1 week. |
HealthDay
17 April at 04.00 PM
Erenumab Effective, Safe for Rosacea-Linked Erythema, FlushingThe anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA Dermatology.Nita K.F. Wienholtz, M.D., Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleag |
MedScape
17 April at 09.37 AM
Study Evaluates Time of Lung Disease Onset With Rare DMRapidly progressive interstitial lung disease was diagnosed in almost half of the patients with MDA5 antibody-positive dermatomyositis. |
MedScape
16 April at 02.08 PM
CDC Investigating Reactions Linked to Counterfeit 'Botox'Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism. |
HealthDay
16 April at 11.40 AM
CDC Warns of 19 Cases of Botched Botox Shots in 9 StatesCounterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the U.S. Centers for Disease Control and Prevention said nine people had been hospitalized and four we |
MedScape
16 April at 06.17 AM
Survey Highlights Impact of Cosmetic-Procedure ComplicationsStudy finds that people who have complications after cosmetic procedures have higher rates of depression, anxiety, and other mental health issues than before the procedures. |
MedScape
16 April at 06.05 AM
Counterfeit Neurotoxin Investigations Prompt Call for ActionThe American Society for Dermatologic Surgery Association emphasized the risks for medical procedures in unlicensed settings. |
MedScape
16 April at 05.35 AM
Review Evaluates Data on Injectables in Skin of ColorIn this literature review, researchers found that neuromodulators and dermal fillers are useful and safe in SOC populations, although more data are needed in some groups. |
MedScape
15 April at 08.49 AM
Survey Highlights Benefits of Pediatric Derm-Rheum ClinicsPediatric dermatology-rheumatology combined clinics improve patient outcomes and satisfaction. |
MedScape
15 April at 02.03 AM
Review Suggests Skin AEs Rare With PD-1/PD-L1 InhibitorsReports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare. |
MedScape
15 April at 01.34 AM
Alopecia Areata: Late Responses to JAK Inhibitors ReportedResponse curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting. |
MedScape
12 April at 09.42 AM
Extension Data Reported for Chronic Hand Eczema TreatmentOver 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues. |
MedScape
12 April at 08.58 AM
Topical Vs Oral Minoxidil for AGA: Which Is More Effective?Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil. |
MedScape
12 April at 08.25 AM
What's Behind Long-Term Antibiotic Prescribing for Acne?"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview. |
HealthDay
10 April at 06.15 PM
Study Identifies Factors That Affect Antibiotic Prescribing for AcneMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a study published online April 3 in JAMA Dermatology.Ronnie A. Festok, from the Emory University School of Medicine in Atlanta, and colleagues conducted a qualitative study assessing data collected from stakeholders (dermatologists, inf |
HealthDay
10 April at 03.57 PM
Bioactive Retinol Efficacious for Improving Signs of PhotoagingStabilized bioactive retinol is efficacious for improving signs of photoaging, without causing major irritation, according to a study published in the April issue of the Journal of Drugs in Dermatology.Patricia Farris, M.D., from Tulane University School of Medicine in New Orleans, and colleagues examined the comprehensive efficacy |
MedScape
10 April at 07.46 AM
New Tool Could Help Screen Patients for Zoom DysmorphiaIndividuals with zoom dysmorphia tend to scrutinize their facial features and fixate on what they think needs to improve and feel pressured to appear perfect before virtual meetings. |
MedScape
10 April at 05.22 AM
Childhood Atopic Dermatitis Linked to IBD RiskA prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease. |
MedScape
09 April at 03.18 AM
Expert Recommends Phased Approach For Delusional InfestationPhase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life. |
MedScape
09 April at 12.35 AM
Hidradenitis Suppurativa: Sonelokimab Shows Promise in StudySonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F. |
HealthDay
08 April at 10.30 PM
FDA Approves New Antibiotic for Three IndicationsThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream infections, adults with acute bacterial skin and skin structure infections, and adult and pediatric patients (age 3 months |
MedScape
05 April at 08.16 AM
Transplant Recipients: Consider Skin Cancer, Infection RisksRecent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients. |
MedScape
05 April at 03.22 AM
Medicare IHC Claims With Melanoma Dxs Increased, Study FindsWith sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors. |
MedScape
05 April at 02.17 AM
FDA Accepts Application for a New HS TreatmentBimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. |
MedScape
04 April at 06.39 AM
Review Describes Semaglutide-Associated Skin EffectsAlopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug. |
HealthDay
03 April at 03.45 PM
Second Primary Malignancy Risk Increased After Cutaneous B-Cell LymphomaPatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.Lauren Banner, from Thomas Jefferson University in Philadelphia, and colleagues used the Surveillance, Epidemiolo |
MedScape
03 April at 06.01 AM
Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus TrialRilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus. |
MedScape
03 April at 03.29 AM
Ruxolitinib Cream Shows Promise for Hidradenitis SuppurativaTreatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa. |
MedScape
03 April at 02.33 AM
Intralesional Wart Treatments Are Among Options to ConsiderAlternatives to SA and cryotherapy for warts may be helpful "for patients who have failed traditional therapies or have a contraindication to the usual go-tos," said Dr Jennifer Adams. |
MedScape
02 April at 07.41 AM
JAK Inhibitors for Vitiligo: More Skin Response Over TimeTwo JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib. |
MedScape
01 April at 01.39 AM
Tooth Enamel Disorder Is a Feature of Kindler EBStudy found that hypoplastic pitted amelogenesis imperfecta is among the oral manifestations of Kindler epidermolysis bullosa, underscoring the need for early and sustained dental care. |
MedScape
01 April at 01.16 AM
Rate of Malignancy Low in Pediatric LMPediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy. |
HealthDay
29 March at 03.14 PM
U.S. Doctors Received Industry Payments of $12.13 Billion From 2013 to 2022U.S. physicians received $12.13 billion from industry from 2013 to 2022, according to a research letter published online March 28 in the Journal of the American Medical Association.Ahmed Sayed, M.B.B.S., from Ain Shams University in Cairo, and colleagues examined the distribution of payments within and across specialties and the medica |
HealthDay
29 March at 11.42 AM
High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA WarnsSome pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided, the U.S. Food and Drug Administration warns.These creams, gels, sprays and soaps are marketed for topical use to relieve the pain of cosmetic procedures like microdermabrasion, laser hair removal, tattooing and <a href="http |
MedScape
27 March at 12.24 PM
FDA Warns Consumers Against Using Some Topical AnalgesicsThe warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures. |
MedScape
26 March at 06.37 AM
Hair-Straightening Products Entail Acute Kidney Failure RiskProducts containing glyoxylic acid were associated with the accumulation of calcium oxalate crystals in the kidneys. |
HealthDay
25 March at 03.55 PM
Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic ProceduresTime spent on social media and use of photo-editing applications contribute to the desire to undergo a cosmetic procedure, according to a study recently published in the Journal of Clinical and Aesthetic Dermatology.Iman F. Khan, M.D., M.P.H., from Boston University, and colleagues surveyed 175 adults visiting an outpatient dermat |
HealthDay
22 March at 10.09 PM
Four in 10 Adults Choose Telemedicine VisitsMany patients, including those with the greatest care needs, choose telemedicine even when in-person visits are available, according to a study published online March 22 in JAMA Network Open.Eva Chang, Ph.D., M.P.H., from Advocate Health in Milwaukee, Wisconsin, and colleagues assessed patient characteristics associated with telem |
HealthDay
22 March at 03.58 PM
Survey Assesses Perspectives on Patient Image Use in DermatologyMost patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research letter published online March 13 in JAMA Dermatology.Trina Salvador, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a s |
HealthDay
22 March at 03.56 PM
Physicians Concerned About Private Equity's Impact on Health CarePhysicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in JAMA Internal Medicine.Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views towa |
MedScape
22 March at 01.58 AM
Acne Products With Benzoyl Peroxide Under ScrutinyIn a citizen's petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate. |
HealthDay
21 March at 10.59 PM
Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022Life expectancy increased to 77.5 years in 2022, while the age-adjusted rate of drug overdose deaths increased from 2002 to 2022 but did not change from 2021 to 2022, according to two March data briefs published by the National Center for Health Statistics.Kenneth D. Kochanek, from the National Center for Health Statistics in Hyattsville, Mar |
MedScape
21 March at 09.16 AM
AI in Dermatology: Consider Its Limitations and ProblemsArtificial intelligence is coming to clinical dermatology, but its enormous promise for improving the lives of patients and physicians will depend on addressing the expected problems. |
MedScape
21 March at 07.58 AM
Immunomodulators Do Not Affect COVID-19 Vaccine EfficacyA study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine. |
MedScape
20 March at 01.03 PM
Study Evaluates Acne Risk With Reversible ContraceptionIn the study, 28.5% of the adolescents and young adults experienced worsening acne after insertion of a progestin-only long-acting reversible contraceptive, and 17% reported acne as a new concern. |
MedScape
20 March at 07.14 AM
FDA Expands Approval of Treatment for GPPSpesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults. |
HealthDay
19 March at 11.05 PM
American Academy of Dermatology, March 8 to 12The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in dermatology. The conference highlighted recent advances in the diagnosis and management of d |
HealthDay
19 March at 03.42 PM
AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in AlopeciaFor adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Brett King, M.D., Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues reported po |
MedScape
19 March at 07.48 AM
Roflumilast Cream Quickly Improved AD in Children, Ages 2-5Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of "clear" or "almost clear" plus a two-grade improvement from baseline at week 4. |
HealthDay
18 March at 03.55 PM
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic DermatitisLebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medicine in New York Ci |
HealthDay
18 March at 03.52 PM
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe AlopeciaMONDAY, March 18, 2024 (HealthDay News) -- Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Rodney D. Sinclair, M.D., from the University of Me |
MedScape
18 March at 05.46 AM
Tips on Managing Acne in Transmasculine PatientsTestosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said. |
HealthDay
15 March at 03.25 PM
AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air PollutionShort-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Alex Ha, from the University of California, San Francisco, and colleagues conducte |
HealthDay
15 March at 03.21 PM
AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe PsoriasisFRIDAY, March 15, 2024 (HealthDay News) -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Bruce Strober, M.D., Ph.D., from the Yale Sc |
MedScape
15 March at 11.40 AM
Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 WeeksThe encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis. |
MedScape
15 March at 05.49 AM
Most Baby Cleansers Are Not 'Allergen-Free,' Study FindsA recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims. |
HealthDay
14 March at 12.04 PM
HHS Opens Investigation Into UnitedHealth CyberattackFollowing a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said Wednesday it has begun an investigation into the incident.In a <a href="https://www.hhs.gov/about/news/2024/03/13/h |
MedScape
14 March at 09.07 AM
Major Responses Seen for Cicatricial and Total Hair LossTwo oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology. |
MedScape
14 March at 06.42 AM
Florida Bill Addresses Coverage of Skin Cancer ScreeningSome 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis. |
HealthDay
13 March at 12.05 PM
Cyberattack Leaves Health Care Providers Reeling Weeks LaterFollowing a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day.That <a href="https://www.ama-assn.org/press-center/press-releases/cyberattack-jeopardizes |
MedScape
13 March at 07.06 AM
2024 AAD Acne Guidelines: Newer Therapies Join Old StandbysA coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news. |
HealthDay
12 March at 10.49 PM
Atopic Dermatitis in Children Tied to Learning, Memory DifficultiesPediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study published online March 6 in JAMA Dermatology.Emily Z. Ma, from the University of Maryland School of Medicine |
MedScape
12 March at 04.54 PM
Lebrikizumab Found Effective for Patients With AD, SOCInterim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI. |
MedScape
11 March at 05.36 PM
Study Eyes Effect of Maternal HS on Outcomes in OffspringThe study population included nearly 1.3 million children born in Quebec, Canada, over a 16-year period. |
MedScape
10 March at 07.53 PM
Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis ControlBoth an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies. |
MedScape
10 March at 05.01 PM
Home- and Office-Based Phototherapy for Psoriasis ComparedThe multicenter LITE trial included 783 patients at 42 sites in the United States. |
MedScape
10 March at 02.29 PM
During Pregnancy, Many Drugs Safe for Skin InfectionsSeveral drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues. |
MedScape
09 March at 04.07 PM
New NCCN Melanoma Guidelines Capture Evolving Best PracticeNCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines. |
MedScape
09 March at 02.41 PM
Novel Drug Shows Promise for Hidradenitis SuppurativaThe findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS. |
MedScape
08 March at 06.28 PM
Flexibility Advised for Patients With Personality DisordersUp to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD. |
HealthDay
08 March at 04.59 PM
AAD: Concerns Noted Relating to Use of AI Dermatology AppsThere are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Shannon Wongvibulsin |
MedScape
08 March at 04.07 PM
Anti-DEI Petition Sparks Conflict at Nat'l Derm MeetingA controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group's annual meeting starting today. |
MedScape
08 March at 08.01 AM
Sulfites Selected as ACDS Allergen of the YearExperts lobby for increased inclusion of sulfites in patch test panels. |
MedScape
08 March at 06.14 AM
Psoriasis Study Shows a Path for Considering US Drug CostsOnly three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations. |
HealthDay
07 March at 02.00 PM
Carcinogen Benzene Can Form in Some Acne Treatments: ReportSome acne treatments may banish blemishes but carry hidden dangers: A new report reveals high levels of the carcinogen benzene can form in products that contain the zit-fighting ingredient benzoyl peroxide.According to the new report from |
MedScape
07 March at 07.06 AM
Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?The analysis included children aged 17 years or younger without intellectual disability or autism. |
HealthDay
06 March at 04.38 PM
Skin of Color Underrepresented in AI Programs in DermatologyChallenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets, according to research published online March 6 in the International Journal of Dermatology.Rebecca Fliorent, from the Rowan-Virtua School of Osteopathic Medicine in St |
MedScape
06 March at 01.53 AM
New Indication Approved for JuvédermIn a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response. |
HealthDay
06 March at 12.00 AM
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp PsoriasisFor scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt in Germany, and colleagues conducted a multicenter, double-blind, vehicle-controlled phase 3 trial to examine the e |
HealthDay
06 March at 12.00 AM
Higher Use of Health Care Portal Seen During COVID-19 PandemicHealth care portal use was higher during the COVID-19 pandemic, according to a study published online Feb. 29 in JAMA Network Open.Esther Yoon, Ph.D., M.P.H., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined the prevalence of health care portal use before, during, and after the most re |
MedScape
04 March at 10.21 PM
FDA Approves Another Neurotoxin for Frown LinesThe product has been sold in more than 50 countries, the company says. |
MedScape
03 March at 11.01 PM
Patient-Reported Outcomes Important in Cutaneous GVHD: StudyThe study results "highlight the importance of patient-reported outcomes in measuring this disease," the study's lead author said. |
MedScape
01 March at 02.06 AM
Review Highlights Evidence of Climate Change Effects on ADAtopic dermatitis "could serve as a case study for climatic impacts on health," the authors emphasized in their paper. |
MedScape
29 February at 11.18 PM
Study Finds No Increased Cancer Risk With SpironolactoneOver 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone. |
MedScape
29 February at 12.45 AM
What’s The Incidence Rate of a Second Primary Melanoma?The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said. |
HealthDay
27 February at 04.59 PM
Delayed Melanoma Care During Pandemic Proved CostlyDelays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in JAMA Network Open.Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associa |
MedScape
27 February at 07.38 AM
What Drives Fatigue in Psoriasis and PsA?Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data. |
HealthDay
26 February at 05.02 PM
Observed Rates of Cancer Diagnoses Lower Than Expected in PandemicDuring the COVID-19 pandemic, cancer diagnoses were lower than expected, according to a study published online Feb. 22 in JAMA Oncology.Todd Burus, from the Markey Cancer Center at the University of Kentucky in Lexington, and colleagues conducted a population-based cross-sectional analysis of cancer incidence trends using data on cases |
MedScape
26 February at 01.47 AM
TikTok Info on Infantile Hemangiomas Suspect: StudyIn a cross-sectional study of the social media platform, researchers analyzed 50 videos on the topic. |
MedScape
26 February at 12.34 AM
Biologic Treatment for Psoriasis Linked to Lower MortalityEvidence to support the hypothesis that the use of systemic immunomodulatory agents for psoriasis "quenches systemic inflammation and potentially improves" survival is limited, investigators said. |
HealthDay
23 February at 11.30 PM
Level of Burnout Higher for Women in Health Care OccupationsWomen in health care occupations endure a significantly higher level of stress and burnout than men, according to a study published online Feb. 21 in Global Advances in Integrative Medicine and Health.Viktoriya Karakcheyeva, M.D., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colle |
MedScape
23 February at 12.38 PM
EMA Approves Tx for Psoriasis and Other Autoimmune DisordersThe biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009. |
MedScape
23 February at 09.00 AM
'Superclinic' Powers Through Skin Cancer ReferralsOne hospital's experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery. |
MedScape
23 February at 01.34 AM
Longer IV Ertapenem Course Beneficial for Recalcitrant HS2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning. |
HealthDay
22 February at 12.17 PM
Jill Biden Announces $100 Million for Research on Women's HealthFirst Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We will build a health care system that puts women and their lived experiences at its center,” Biden said in a White House <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/02/21/remarks-as-prepared-for-deliv |
MedScape
22 February at 08.13 AM
One-a-Day Pill for Alopecia Recommended for NHS UseNICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people. |
HealthDay
21 February at 04.01 PM
Clinical Markers Improve With IV Ertapenem for Hidradenitis SuppurativaTreatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.Avigdor Nosrati, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a retrospective rev |
HealthDay
21 February at 01.45 PM
This Election Year, Health Care Costs Top Voter Concerns: PollUnexpected medical bills and high health care costs are dominating an election where kitchen table economic problems weigh heavily on voter’s minds, a new KFF poll has found.Voters struggling to pay their monthly bills are most eager to hear presidential candidates talk about economic and health care issues, according to the latest KFF Health |
MedScape
21 February at 02.12 AM
Nemolizumab Being Reviewed for AD, Prurigo NodularisFor prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review. |
MedScape
20 February at 10.49 PM
What Skin Manifestations Are Associated With Pediatric IBD?Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common. |
HealthDay
20 February at 04.26 PM
Amtagvi Approved by the FDA for Treatment of Advanced MelanomaAmtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer."The approval of Amtagvi offers hope to those with advanced melanoma who have progressed following initial standard-of-care therapies |
HealthDay
17 February at 12.00 AM
Expanded Use of Xolair to Treat Food Allergies Approved by the FDAThe U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other anaphylaxis rescue remedies, the agency stressed. Instead, "Xolair is intended for repeated use to reduce the risk of allergic re |
HealthDay
16 February at 04.32 PM
Deep Learning Improves Diagnostic Accuracy for Skin DiseasesDeep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatol |
MedScape
16 February at 12.53 AM
Cellulite: Outcomes 1 Year After Noninvasive TreatmentThe findings build on results from a 12-week study of the device, which the investigators said "induces physical shearing of fibrous septa through rapid acoustic pulses." |
MedScape
16 February at 12.02 AM
Tapinarof Under FDA Review for Treating Atopic DermatitisApproved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older. |
HealthDay
15 February at 04.42 PM
FDA Approves Aurlumyn for Severe FrostbiteAurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation."This approval provides patients with the first-ever treatment option for severe frostbite," Norman Stockbridge, M.D., director of the Division of Cardiol |
HealthDay
14 February at 11.06 PM
Study Looks at Access to U.S. Burn Centers Using 2019 DataAccess disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified a |
MedScape
14 February at 02.14 AM
Lab Testing in Patients on Immunomodulators Falls ShortReview found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment. |
MedScape
13 February at 11.11 PM
Tinea Capitis Management in Kids Varies, Survey FindsRespondents included 56 members of the Pediatric Dermatology Research Alliance. |
HealthDay
12 February at 04.17 PM
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes VariesThe association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospectiv |
HealthDay
12 February at 04.13 PM
Smoking Linked to Melanoma-Associated Death in Early-Stage MelanomaFor patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 in JAMA Network Open.Katherine M. Jackson, M.D., from the Saint John's Cancer Institute at Providence Saint John's Health Center in Santa Monica, California, and col |
MedScape
09 February at 05.04 PM
Tools on the Horizon for Managing Posttransplant cSCC RiskOrgan transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. |
HealthDay
09 February at 04.56 PM
Health Care Costs, Resource Utilization Increased for Vitiligo PatientsPatients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of Investigative Dermatology.Khaled Ezzedine, M.D., from Henri Mondor University Hospital in Créteil, France, and colleagues conducted a retrospective cohort analysis |
MedScape
09 February at 04.42 PM
Analysis Finds Allergens in Many Topical Scar ProductsOf the 156 products identified, most were gels, creams, or oils. |
MedScape
09 February at 05.44 AM
Spitz Nevi: An Expert Shares Tips for Diagnosis, ManagementDr Caroline Piggott provides her perspective on dermoscopy, shave vs punch biopsies, and treatment. |
MedScape
09 February at 02.26 AM
Periocular Melanoma Still Rare, But May Be IncreasingPain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants. |
MedScape
09 February at 12.38 AM
Study Shows Disparities in Diagnosing Across Skin TonesAcross all images, diseases in darker skin types were diagnosed less accurately than diseases in lighter skin types, including when decision support from a deep learning system was introduced. |
HealthDay
08 February at 04.39 PM
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque PsoriasisFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England Journal of Medicine.Robert Bissonnette, M.D., from Innovaderm Research in Montreal, and colleagues conducted a phas |
MedScape
07 February at 11.18 PM
Lifetime Cost of DEB Gene Therapy Could Be $15-$22 MillionThe most expensive gene therapy on the US market may give payers pause, said study authors. |
MedScape
07 February at 05.09 PM
Oral IL-23 Inhibitor Calms Moderate to Severe PsoriasisThe small-molecule oral investigational agent JNJ-77242113 at the highest dose tested was associated with reductions in psoriasis severity comparable to injectable biologic agents. |
MedScape
07 February at 06.09 AM
AAD Updates Acne Management GuidelinesThe new guidelines updated the AAD's 2016 guidelines and included 18 recommendations and five good practice statements. |
MedScape
06 February at 01.46 AM
Dupilumab Improves AD Affecting the Hands, FeetDupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis. |
MedScape
06 February at 01.37 AM
MACE, VTE Risks Not Increased With JAK inhibitors: StudyIn studies with an average follow-up of 16 weeks, there was no significant increase in MACE or VTE rates in people with dermatoses treated with JAK-STAT inhibitors. |
HealthDay
05 February at 11.45 PM
Price of Prescription Drugs Almost Threefold Higher in the United StatesPrescription drug prices are nearly three times higher in the United States than in other countries, according to a report published by the RAND Corporation.Andrew W. Mulcahy, and colleagues from the RAND Corporation, compared the prices of different categories of drug products, including brand-name originator drugs, unbranded generic drugs, biol |
HealthDay
05 February at 04.29 PM
AAD Updates Guidelines for Management of Acne VulgarisIn guidelines issued by the American Academy of Dermatology and published online Jan. 30 in the Journal of the American Academy of Dermatology, updated recommendations are presented for the management of acne vulgaris.Rachel V. Reynolds, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a systematic revi |
HealthDay
02 February at 03.50 PM
Gender Minority Adults Are Vulnerable During Full Body Skin ExamWithin the sexual and gender minority (SGM) population, gender minority adults are more likely to report discomfort during full body skin examinations (FBSEs), according to a research letter published online Jan. 31 in JAMA Dermatology.Michelle Verghese, from the Pritzker School of Medicine at the University of Chicago, and colleagues us |
MedScape
01 February at 02.06 AM
Rosacea and Recent Research Back Potential New TherapiesWhat do botulinum toxin, paroxetine, and a low-molecular-weight heparan sulfate analog have in common? Each has evidence as a potential treatment for people with rosacea. |
MedScape
31 January at 11.32 PM
Successful Acne Scar Treatment Can Boost Quality of LifeThe three main types of acne scars can dictate the approach to treatment. |
HealthDay
29 January at 10.54 PM
Practitioner Empathy Interventions Can Improve Patient SatisfactionHealth care practitioner empathy interventions seem to improve patient satisfaction, but inadequate reporting hinders the ability to draw definitive conclusions relating to the overall effect size, according to a review published online Jan. 30 in the Annals of Internal Medicine.Leila Keshtkar, Ph.D., from the University of Leicester in |
HealthDay
29 January at 04.10 PM
Early FDG PET/CT Can ID Metabolic Changes in Advanced MelanomaFor patients with advanced melanoma, early 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging can identify metabolic changes that may predict response to pembrolizumab, according to a study published online Jan. 24 in Clinical Cancer Research.Thomas M. Anderson, M.D., from the Per |
HealthDay
25 January at 10.58 PM
2004 to 2019 Saw Increase in Isotretinoin Use in Girls, WomenFrom 2004 to 2019, there was an increase in isotretinoin use among girls and women of childbearing age in Germany, according to a study published online Jan. 25 in PLOS Medicine.Jonas Reinold, from the Leibniz Institute for Prevention Research and Epidemiology–BIPS in Bremen, Germany, and colleagues determined the age-standardized pre |
MedScape
25 January at 10.59 AM
Think Outside the Traditional Toolbox to Treat ItchNaloxone and strontium are just a few of the "out of the box" therapies dermatologists can consider for treating chronic itch. |
MedScape
25 January at 06.42 AM
Emerging Therapies Foretell New Era for Cutaneous DisordersAnalogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders. |
HealthDay
24 January at 04.55 PM
Climatic Hazards Linked to Aggravation of Atopic DermatitisClimatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in Allergy.Sheng-Pei Wang, M.D., M.P.H., from the University of California San Francisco, and colleagues identified 18 studies with evidence for an impact of AD by leve |
MedScape
24 January at 11.00 AM
How Does Rituximab for Pemphigus Fare in the Long Term?This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent. |
HealthDay
23 January at 04.18 PM
Apremilast May Offer Cardiometabolic Benefit in Psoriasis PatientsFor patients with moderate-to-severe psoriasis, apremilast appears to have a neutral association with aortic vascular inflammation, generally beneficial associations with certain cardiometabolic biomarkers, and associations with reductions in visceral and subcutaneous fat, according to a study published online Sept. 21 in JAMA Dermatology. |
MedScape
23 January at 10.26 AM
Study Finds Multidisciplinary Pediatric AD Clinic BeneficialThe clinic is a collaborative effort between Rady Children's Hospital and the University of California San Diego Health Divisions of Dermatology, Allergy & Immunology, and the hospital's pharmacy. |
MedScape
23 January at 03.49 AM
Hair Creams: Do You Know the Health Risks?Some products may be easy on the hair but hard on the eyes. |
HealthDay
22 January at 10.13 PM
Older Adults Average 20.7 Total Health Care Contact Days a YearOlder adults have a mean of 20.7 total health care contact days per year, according to a study published online Jan. 23 in the Annals of Internal Medicine.Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues characterized health care contact days among community-dwelling adults aged 65 years and olde |
MedScape
22 January at 08.46 AM
Diet and Skin: What is the Evidence?There are scientific studies linking dietary factors to acne, atopic dermatitis, rosacea, and other common skin conditions. |
MedScape
22 January at 02.44 AM
Hair Loss in Children: How to Dx and Treat Different CausesTopical and systemic treatments can help children and teens regrow hair and reduce anxiety and bullying. |
HealthDay
20 January at 12.01 AM
Study IDs Risks to Offspring Associated With Prenatal Opioid ExposurePrenatal opioid exposure (POE) is associated with an increased risk for infection, eczema and dermatitis, and asthma in offspring, but it is not linked to allergies or anaphylaxis, according to a study published online Jan. 17 in JAMA Network Open.Erin Kelty, Ph.D., from the University of Western Australia in Crawley, and colleagues com |
HealthDay
19 January at 05.24 PM
Bidirectional Link ID'd for Autoimmune Disease, Perinatal DepressionThere is a bidirectional association between autoimmune disease (AD) and perinatal depression (PND), according to a study published online Jan. 9 in Molecular Psychiatry.Emma Bränn, from the Karolinska Institutet in Stockholm, and colleagues examined the bidirectional association between PND and AD using nationwide Swedish population an |
MedScape
19 January at 04.30 AM
Smoking Associated With Risk for Hair Loss Among MenThe risk for progression of androgenetic alopecia is higher among those who smoke as well, according to an analysis. |
MedScape
18 January at 03.57 AM
New Molecules Reflect Advances in Atopic DermatitisTopical formulations of JAK inhibitors could help treat moderate to severe atopic dermatitis in adults and adolescents, said one dermatologist. |
MedScape
17 January at 05.41 PM
AI-Powered Device Cleared as Noninvasive Skin Cancer TestThe handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds. |
HealthDay
17 January at 04.58 PM
Inflammation, Poverty Have Synergistic Effect on MortalityThere is a potential synergistic effect for inflammation and living in poverty with increased mortality risk for adults, according to a study published online Jan. 16 in Frontiers in Medicine.Arch G. Mainous III, Ph.D., from the University of Florida in Gainesville, and colleagues examined whether there is a synergistic effect of the |
HealthDay
17 January at 04.55 PM
Factors ID'd That Affect Medical Decision-Making in Hidradenitis SuppurativaFactors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, according to a study published online Jan. 10 in JAMA Dermatology.Nicole Salame, M.D., from the Emory Un |
MedScape
17 January at 07.38 AM
Review Spotlights Effects of Epidermolysis Bullosa on BonesResearchers summarized recommendations from 13 published studies. |
MedScape
15 January at 05.32 AM
Study Estimates Post-COVID Risk for Alopecia AreataThe incidence of alopecia areata in patients with COVID-19 was significantly higher than that in the uninfected controls, in a large Korean cohort study. |
MedScape
15 January at 02.14 AM
How Should Dermatologists Confront Suspected Drug Allergies?Checking for and categorizing a suspected allergy allows physicians to draw up a management plan. |
MedScape
15 January at 02.06 AM
Etiology Elusive in Nearly 40% Cases of Urticaria in InfantsSymptoms are most likely to resolve spontaneously, researchers said. |
HealthDay
13 January at 12.12 AM
Substance Use Disorders on the Rise for Survivors of Specific CancersThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.Katie F. Jones, Ph.D., from VA Boston Healthcare System, and colleagues describe cancer type-specific prevalence of SUD among adult cancer survivors in a cross-sec |
HealthDay
11 January at 09.45 PM
12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021In 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 million, according to research published in the Jan. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.< |
HealthDay
11 January at 09.34 PM
Affordable Care Act Sees Record Number of Americans Signing UpWith only days left before open enrollment closes, the Biden administration announced Wednesday that 20 million Americans have already signed up for health insurance under the Affordable Care Act."Today, we hit a major milestone in lowering costs and ensuring all Americans have access to quality, affordable health care. With six days left to s |
HealthDay
11 January at 04.48 PM
CDC: 5.7 Percent of Adults Lacked Reliable Transportation in 2022In 2022, 5.7 percent of adults reported lacking reliable transportation for daily living, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Amanda E. Ng, Ph.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues u |
MedScape
11 January at 02.53 AM
What Factors Affect Treatment Decisions in Patients With HS?Dermatologists can empower patients to make informed, meaningful treatment choices, the authors said. |
MedScape
11 January at 12.37 AM
Probiotics, Other Supplements May Benefit Patients With AcneMyo-inositol is among the other supplements, with evidence showing they can help in patients with acne, experts said at an integrative dermatology meeting. |
MedScape
10 January at 05.30 AM
Clascoterone Efficacy or Acne Increased Over Time: AnalysisResearchers integrated data from two pivotal trials and a long-term extension study. |
MedScape
10 January at 05.30 AM
Clascoterone Efficacy for Acne Increased Over Time: AnalysisResearchers integrated data from two pivotal trials and a long-term extension study. |
MedScape
09 January at 01.45 AM
AAAAI/ACAAI Task Force Updates AD Management GuidelinesThe guidelines include 25 recommendations and address optimal use of treatments, including topical and systemic treatments, bleach baths, dietary elimination, allergen immunotherapy, and phototherapy. |
MedScape
08 January at 09.57 AM
Study Identifies CV Comorbidities Linked to DermatomyositisThe results "represent potential areas for preventative intervention," the researchers wrote. |
HealthDay
08 January at 04.59 AM
Suicide Risk Increased for Some U.S. Health Care WorkersRegistered nurses, health technicians, and health care support workers have an increased risk for suicide compared with non-health care workers, according to a study published in the Sept. 26 issue of the Journal of the American Medical Association.Mark Olfson, M.D., M.P.H., from Columbia University and the New York State Psychiatric |
HealthDay
07 January at 04.59 AM
U.S. Safety-Net Providers Report Moral Distress in Early PandemicMoral distress during the first nine months of the pandemic was reported by a majority of clinicians working in U.S. safety net practices, according to a study published online Aug. 25 in BMJ Open.Donald E. Pathman, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues examined causes and levels of moral dis |
HealthDay
07 January at 04.59 AM
Child Care Stress Affects Health, Work of U.S. HCWs During PandemicChild care stress (CCS) during the pandemic is associated with anxiety, depression, burnout, intent to reduce hours, and intent to leave among health care workers (HCWs), according to a study published online July 18 in JAMA Network Open.Elizabeth M. Harry, M.D., from the University of Colorado in Aurora, and colleagues assessed whether |
HealthDay
07 January at 04.59 AM
COVID-19 Pandemic Tied to Burnout in Health Care ProfessionalsThe COVID-19 pandemic is associated with higher burnout among health care professionals (HCPs), particularly patient-facing HCPs, according to a study published online Sept. 27 in BJPsych Open.Vikas Kapil, M.B.B.S., Ph.D., from the Queen Mary University of London, and colleagues longitudinally examined mental health in 1,574 HCPs vers |
MedScape
05 January at 06.52 PM
FDA Gives Nod to Berdazimer Gel for Molluscum ContagiosumThe topical treatment is expected to be commercially available in the second half of 2024. |
MedScape
05 January at 05.25 AM
Impact of Pregnancy on Rosacea Unpredictable, Study SuggestsNearly half of study participants reported that their rosacea worsened when they were pregnant. |
MedScape
05 January at 05.23 AM
Expert Highlights Biologics in the Pipeline for EczemaDr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors. |
MedScape
04 January at 07.59 AM
US Dermatologic Drug Approvals Rose Between 2012 and 2022Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said. |
HealthDay
04 January at 04.59 AM
Stress-Management Interventions May Aid Health Care WorkersStress-management interventions may help individual health care workers over the short term, according to research published online May 12 in the Cochrane Database of Systematic Reviews.Sietske J. Tamminga, Ph.D., from the University of Amsterdam, and colleagues conducted a systematic review to evaluate the effectiveness of stress-red |
MedScape
04 January at 02.06 AM
Assessing Patients With AD: Tools to Use in the Office"It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC. |
MedScape
04 January at 01.09 AM
Experimental Topical Drug Shows Promise for AD, PsoriasisIn the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks. |
HealthDay
03 January at 10.48 PM
Transgender, Gender-Diverse Individuals Report Acne-Related StigmaTransgender and gender-diverse individuals report experiencing acne-related stigma, according to a study published online Jan. 3 in JAMA Dermatology.Sarah Gold, from the Emory University School of Medicine in Atlanta, and colleagues conducted a mixed-methods analysis at a multidisciplinary gender center using semistructured interviews |
HealthDay
03 January at 04.04 PM
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to WildfiresAn increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related clinic visits in a Boston hospital system, according to a study published online Dec. 16 in Dermatology and Therapy.Kathyana P. Santiago Mangual, from Massachusetts |
MedScape
03 January at 01.14 AM
5-Year Safety Data From Upadacitinib Trials ReportedUpadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick. |
MedScape
03 January at 01.14 AM
5-Year Safety Data From Upadacitinib Trials ReportedUpadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick. |
HealthDay
30 December at 04.59 AM
Model Predicts New Psoriatic Arthritis in People With PsoriasisThe development of psoriatic arthritis (PsA) can be predicted with reasonable accuracy for psoriasis patients, according to a study published online Aug. 9 in Arthritis & Rheumatology.Lihi Eder, M.D., Ph.D., from University of Toronto, and colleagues developed a risk prediction model (<a href="http://sharpmindtill120.x10host.co |
HealthDay
29 December at 04.10 PM
Biological Agent Trials for Psoriasis Rarely Include Patient ImagesFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online Nov. 15 in the Journal of Dermatological Treatment.Sam Polesie, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues conducted a systematic review to assess the proportio |
MedScape
29 December at 11.05 AM
Conjunctivitis: How Common Is It in Patients on Dupilumab?Adults with AD have a significant and disease severity–dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis. |
HealthDay
28 December at 05.02 PM
Updated Guidelines Released for Management of Atopic DermatitisIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in the Annals of Allergy, Asthma & Immunology, recommendations are presented for gaining and maintaining control of atopic dermatitis (AD).Derek K. Chu, M.D., Ph.D. |
HealthDay
26 December at 10.37 PM
More Than Half of U.S. Medical Interns Experience Sexual HarassmentMore than half of U.S. medical interns report experiencing sexual harassment, according to a research letter published online Dec. 26 in JAMA Network Open.Elizabeth M. Viglianti, M.D., from the University of Michigan in Ann Arbor, and colleagues investigated possible institutional variation in experiences of sexual harassment amon |
MedScape
26 December at 02.14 AM
Keeping Injectable Products in Cosmetic Dermatology SafeThe rapid increase in intradermal injections of hyaluronic acid and Botox has been accompanied by an increase in side effects. |
MedScape
26 December at 01.27 AM
FDA approves topical treatment for junctional, dystrophic EBThis is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023. |
MedScape
26 December at 12.26 AM
Study Links Specific Drugs to Delusions of Parasitosis RiskResearchers conducted a case-control study of biometric and pharmaceutical data from 34 patients with delusions of parasitosis, which they compared to an age-matched control group of 53 women. |
HealthDay
22 December at 10.35 PM
One in Five New Dermatology Drugs Were First in Class Over the Past DecadeFrom 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology.Samir Kamat, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues characterized the frequency and degree of innovation of new dermatologic drugs (topic |
MedScape
22 December at 12.24 AM
Paradoxical Eczema Risk Low With Biologic Psoriasis TxAli Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema. |
HealthDay
21 December at 04.51 PM
Risk for Vitiligo Increased for Transplant RecipientsTransplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology.Chul Hwan Bang, M.D., Ph.D., from the Catholic University of Korea in Seoul, and colleagues conducted a population-based cohort study |
MedScape
21 December at 09.28 AM
Evaluating Aesthetic Concerns Among Hispanic, Latinx WomenTo date, the aesthetic needs of Hispanic/Latinx patients, the second largest ethnic group in the United States, have been poorly understood. |
HealthDay
21 December at 04.59 AM
Air Pollution Tied to Multimorbidity Status, SeverityExposure to air pollution is associated with having multimorbid, multiorgan conditions, according to a study published online Dec. 2 in Frontiers in Public Health.Amy Ronaldson, Ph.D., from King’s College London, and colleagues examined associations between long-term air pollution exposure and multimorbidity status, severity, and pat |
HealthDay
20 December at 11.11 PM
Osteoporosis Risk Increased With Long-Term Topical Corticosteroid ExposureThe risk for osteoporosis and major osteoporotic fracture (MOF) is increased in association with long-term exposure to topical corticosteroids (TCSs), according to a study published online Dec. 20 in the Journal of the European Academy of Dermatology and Venereology.Bing-Jun Hsieh, from the National Taiwan University Hospital in Taip |
HealthDay
20 December at 10.02 PM
Burnout, Lack of Fulfillment Linked to Physician Intention to LeaveBurnout, lack of professional fulfillment, and other well-being-linked factors are associated with intention to leave (ITL) among physicians, according to a study published online Dec. 15 in JAMA Network Open.Jennifer A. Ligibel, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues describe the prevalence of burnout, |
MedScape
20 December at 02.21 AM
Reducing CVD Morbidity and Mortality in Psoriasis and PsAOnly a minority of patients with psoriatic disease know about their increased risks. |
HealthDay
19 December at 04.58 PM
Artificial Intelligence Models Improve Clinicians' Diagnostic AccuracyStandard artificial intelligence (AI) models improve diagnostic accuracy, but systematically biased AI models reduce this accuracy, according to a study published in the Dec. 19 issue of the Journal of the American Medical Association.Sarah Jabbour, from the University of Michigan in Ann Arbor, and colleagues examined the impact of sys |
MedScape
18 December at 04.46 PM
Roflumilast Foam Gets Nod for Seborrheic DermatitisPatients in the roflumilast group showed significant improvements in all secondary endpoints, including itching, scaling, and erythema. |
HealthDay
18 December at 04.25 PM
Risk for Skin Cancer Increased for Patients With Lower Extremity LymphedemaPatients with lower extremity (LE) lymphedema have an increased risk for skin cancer, especially basal cell carcinoma, according to a study published online in the November issue of Mayo Clinic Proceedings.Nimay C. Anand, M.D., from Meharry Medical College in Nashville, Tennessee, and colleagues conducted a retrospective cohort study in |
MedScape
18 December at 02.18 PM
How Does Lebrikizumab Perform Across Different Subgroups?Key eligibility criteria for both trials included adults or adolescents with a diagnosis of AD as defined by the AAD consensus criteria, for at least 1 year prior to screening. |
MedScape
18 December at 02.06 PM
GVHD Raises Vitiligo Risk in Transplant Recipients"The findings suggest that early detection and management of vitiligo lesions can be improved by estimating the likelihood of its development in transplant recipients..." |
MedScape
18 December at 03.37 AM
Pilot Study Educates Barbers About Pseudofolliculitis BarbaeIn the study, barbers received questionnaires before and after an educational session on the recognition, cause, prevention, and treatment of PFB, which disproportionately affects Black men. |
HealthDay
15 December at 08.44 PM
Efficacy Shown for New Melanoma Therapeutic VaccineIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49 percent less likely to die or have their cancer return after three yea |
MedScape
15 December at 05.16 PM
FDA Approves Tralokinumab for Treating Eczema in AdolescentsIt is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine. |
HealthDay
15 December at 12.00 AM
More Senior Physicians See Fewer Underserved PatientsSenior physicians treat fewer traditionally underserved patients than their junior colleagues within the same practices, according to a research letter published online Dec. 13 in JAMA Network Open.Hannah T. Neprash, Ph.D., from University of Minnesota School of Public Health in Minneapolis, and colleagues examined the associatio |
MedScape
14 December at 05.00 PM
Disease Control Elusive for Many Patients on AD TherapiesA significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia." |
HealthDay
14 December at 05.00 PM
Blacks More Likely to Have Disseminated Manifestations of Lyme DiseaseBlack patients are more likely to be diagnosed with disseminated manifestations of Lyme disease (LD) and experience longer time to appropriate treatment, according to a research letter published online Dec. 12 in JAMA Network Open.Samuel J. Starke, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues |
MedScape
12 December at 05.03 PM
Acne Stigma Persists Across Social and Professional SettingsIndividuals with severe acne were considered less attractive, less worthy of friendship, and less likely to be hired for a job compared with those who did not have acne. |
HealthDay
12 December at 04.05 PM
ChatGPT Shows Poor Performance in Answering Drug-Related QuestionsChatGPT provided no response or incomplete or wrong answers to nearly three-quarters of drug-related questions reviewed by pharmacists, according to a study presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, held from Dec. 3 to 7 in Anaheim, California.Sara Grossman, Pharm.D., from Long Island University in |
MedScape
12 December at 12.00 PM
Bimekizumab Promising for Palmoplantar Pustular PsoriasisPPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory." |
HealthDay
11 December at 04.46 PM
Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae CareAn educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB), according to a research letter published online Dec. 6 in JAMA Dermatology.Xavier Rice, M.D., from the University of Texas Medical Branch in Galveston, and colleagues |
MedScape
11 December at 06.13 AM
Study Eyes Melanoma Characteristics in AI/AN PopulationThe primary site with the highest mortality risk was the trunk. |
MedScape
08 December at 05.21 PM
Tape Strips Detect Hidradenitis Suppurativa Biomarkers"Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice." |
MedScape
08 December at 04.28 PM
Combined Rituximab + Omalizumab Promising for Refractory BPBullous pemphigoid has high morbidity and mortality, especially in people with comorbidities common to older adults, yet no Food and Drug Administration–approved therapies for BP exist. |
HealthDay
07 December at 10.56 PM
Stigmatizing Attitudes Identified Toward Individuals With AcneStigmatizing attitudes toward individuals with acne are observed across a range of social and professional scenarios, according to a study published online Dec. 6 in JAMA Dermatology.Ali Shields, from Drexel University College of Medicine in Philadelphia, and colleagues conducted a cross-sectional internet survey study to explore the d |
HealthDay
07 December at 10.40 PM
White House Looks to Curb Big Pharma's Sky-High Drug PricesIn a push for lower drug prices, the Biden administration is warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication is too expensive. Federal law allows the government to grant patent licenses if taxpayer dollars were used in the development of inventions -- including drugs.In a <a href="ht |
MedScape
07 December at 05.19 PM
Patients With hEDS Report Skin Laxity, ScarringFollicular occlusion, mast cell disease, and eczema were common presentations among patients with hypermobile Ehlers Danlos syndrome. |
HealthDay
06 December at 10.59 PM
Many Patients of Color Expect and Prepare for Unfair Health CareMinorities often feel a deep sense of dread before doctor appointments, and some even try to dress especially well for their visit to try and ward off the possibility they will face insults or unfair care. According to a new poll conducted by hea |
MedScape
06 December at 07.01 PM
How Can Dermatologists Improve Cancer Care?Dermatologists play a key role on interdisciplinary treatment teams. |
MedScape
06 December at 04.30 PM
FDA Mandates Changes to iPLEDGE Program for IsotretinoinIsotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin. |
MedScape
05 December at 06.56 PM
Hope Emerges for Patients With Rare Skin Disorder"A new framework for thinking about and treating these diseases is emerging." |
HealthDay
04 December at 10.24 PM
No Increased Suicide Risk Observed for Isotretinoin UsersIsotretinoin users do not have an increased risk for suicide or psychiatric disorders and may have a lower risk for suicide attempts, according to a review published online Nov. 29 in JAMA Dermatology.Nicole Kye Wen Tan, from the National University of Singapore School of Medicine, and colleagues clarified the absolute and relative risks |
MedScape
04 December at 08.05 PM
What's New in Acne Treatment?Advances in acne care include the use of light-based devices. |
MedScape
04 December at 05.39 PM
Analysis Supports Link Between Psoriasis and OSASeveral hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors. |
MedScape
03 December at 05.25 PM
New Tools Available to Help Diagnose Skin CancerEmerging technologies aim to improve skin cancer diagnosis without biopsies. |
MedScape
02 December at 12.19 PM
Misdiagnoses Among Challenges in Managing Cutaneous LymphomaAlthough predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes. |
HealthDay
01 December at 05.00 PM
Ichthyosis Tied to Increased Risk of Depression, AnxietyIchthyosis is associated with increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology. Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis and |
HealthDay
01 December at 05.00 PM
Ichthyosis Tied to Increased Risk for Depression, AnxietyIchthyosis is associated with an increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology. Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis |
MedScape
01 December at 10.49 AM
Novel Subcutaneous Biologics Show Promise in ADPatients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials. |
MedScape
01 December at 08.10 AM
Meta-Analysis: Suicide Risk Not Increased With IsotretinoinIn fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors. |
MedScape
30 November at 02.31 PM
Dietary Supplements May Play a Role in Managing VitiligoDietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy. |
MedScape
30 November at 01.34 PM
Pilonidal Disease: Study Finds Laser Hair Removal BeneficialThe study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease. |
HealthDay
29 November at 04.37 PM
AI Accurate in Diagnosing Suspicious Skin LesionsA mobile phone-powered artificial intelligence (AI) technology is effective for diagnosing suspicious skin lesions, according to a study published in the October issue of The Lancet Digital Health.Scott W. Menzies, Ph.D., from the University of Sydney, and colleagues compared the accuracy of AI algorithms and clinicians for the |
MedScape
28 November at 07.24 PM
Tapinarof Effective for AD in Patients as Young as 2 yearsTapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults. |
MedScape
28 November at 05.52 PM
Nail Psoriasis in Black Patients Often OverlookedUnderrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed. |
MedScape
28 November at 02.18 PM
HS: Positive Results Reported With Anti-IL17A/F TherapiesOne of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies. |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
HealthDay
23 October at 10.58 PM
Risk for Psychiatric Disorders Up for Offspring of Moms With Eating DisorderOffspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula |